Patient Interface

The patient interface with a customizable seal-forming structure and stabilizing mechanism addresses the issues of discomfort and fit in existing respiratory treatment devices, enhancing compliance and therapy effectiveness by securely sealing to diverse facial shapes.

JP7583074B2Active Publication Date: 2024-11-13RESMED PTY LTD
View PDF 18 Cites 0 Cited by

Patent Information

Application Number
JP2023008824
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-08-20
Filing Date
2023-01-24
Publication Date
2024-11-13
Estimated Expiration
2039-08-20

AI Technical Summary

Technical Problem

Existing respiratory treatment devices, such as CPAP therapy masks, suffer from discomfort, poor fit, and reduced patient compliance due to inadequate seal-forming structures and stabilization mechanisms, leading to inefficiencies in treating respiratory disorders.

Method used

A patient interface with a seal-forming structure that includes lateral support regions, an intermediate region, and a plenum chamber designed to accommodate various facial shapes, along with a positioning and stabilizing structure to maintain a therapeutic seal, allowing for comfortable and effective delivery of pressurized air while minimizing leakage.

Benefits of technology

The design enhances patient comfort and compliance by providing a secure seal that adapts to individual facial contours, reducing noise and leakage, and improving the effectiveness of respiratory therapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583074000004
    Figure 0007583074000004
  • Figure 0007583074000005
    Figure 0007583074000005
  • Figure 0007583074000006
    Figure 0007583074000006
Patent Text Reader

Abstract

The present invention provides medical devices for use in screening, diagnosing, monitoring, ameliorating, treating, or preventing respiratory diseases. [Solution] The patient interface may include a plenum chamber pressurizable to a therapeutic pressure, a seal-forming structure constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, a positioning and stabilizing structure that provides a force to hold the seal-forming structure in a therapeutically effective position on the patient's head, and a venting structure for allowing continuous flow of gases exhaled by the patient from the interior of the plenum chamber to the atmosphere. The patient interface is configured to leave the patient's mouth exposed during treatment. The seal-forming structure includes two lateral support regions, each located on the lateral extreme sides of the seal-forming structure, and a middle region located between the lateral support regions. A hole passes through the middle region, and the lateral support regions are thicker than the middle region.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the reproduction by any person of this patent document or the patent disclosure by facsimile, for purposes of disclosure in the Patent and Trademark Office patent file or records, but reserves all copyright rights thereto for all other purposes.

[0002] 1 CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application No. 62 / 764,992, filed Aug. 20, 2018, which is incorporated herein by reference in its entirety. [Background technology]

[0003] 2. Technology Background 2.1 Technology field The present technology relates to one or more of screening, diagnosing, monitoring, treating, preventing and ameliorating respiratory-related disorders. The present technology also relates to medical devices or apparatus and uses thereof.

[0004] 2.2 Description of Related Art 2.2.1 The human respiratory system and its diseases The body's respiratory system facilitates gas exchange. The nose and oral cavity form the entrance to a patient's airways.

[0005] These airways contain a series of branching tubes that become narrower, shorter and more numerous the deeper they go into the lungs. The primary function of the lungs is gas exchange, allowing oxygen to enter the venous blood from the air and carbon dioxide to leave. The trachea divides into right and left main bronchi, which further divide into terminal bronchioles. The bronchi constitute the conducting airways and do not participate in gas exchange. The airways further divide into respiratory bronchioles and finally into alveoli. Gas exchange occurs in the alveolar region of the lungs, which is called the respiratory region. See: "Respiratory Physiology", by John B. West, Lippincott Williams & Wilkins, 9th edition published 2012.

[0006] There is a range of respiratory diseases. Particular diseases can be characterized by particular manifestations such as apnea, hypopnea and hyperpnea.

[0007] Examples of respiratory diseases include obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory failure, obesity hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular diseases (NMD) and chest wall diseases.

[0008] Obstructive sleep apnea (OSA) is a form of sleep-disordered breathing (SDB) characterized by episodes such as closure or obstruction of the upper airway during sleep. It is the result of an abnormally small upper airway combined with the normal loss of muscle tone in the region of the tongue, soft palate and posterior oropharyngeal wall during sleep. The condition causes affected patients to pause breathing, typically for 30-120 seconds, sometimes as many as 200-300 times per night. This results in excessive daytime sleepiness, which can lead to cardiovascular disease and brain damage. The condition is common, especially in middle-aged overweight men, but patients are asymptomatic. See US Pat. No. 5,399,363 (Sullivan).

[0009] Cheyne-Stokes respiration (CSR) is another form of sleep-disordered breathing. CSR is a disease of the patient's respiratory regulator, followed by alternating periods of waxing and waning ventilation, known as the CSR cycle. CSR is characterized by repeated deoxygenation and reaeration of arterial blood. Because of the repeated hypoxia, CSR can be harmful. In some patients, CSR is accompanied by recurrent sleep arousals, which cause severe insomnia, increased sympathetic activity, and increased afterload. See US Pat. No. 5,399,313 (Berthon-Jones).

[0010] Respiratory failure is a general term for respiratory disorders that refers to the inability of the lungs to take in enough oxygen or breathe out enough CO2 to meet the patient's needs. Respiratory failure can include some or all of the following conditions:

[0011] Patients with respiratory failure (a type of respiratory insufficiency) may experience abnormal shortness of breath during exercise.

[0012] Obesity hyperventilation syndrome (OHS) is defined as the combination of severe obesity and chronic awake hypercapnia in the absence of any other clear cause of hypoventilation. Symptoms include dyspnea, morning headache, and excessive daytime sleepiness.

[0013] Chronic obstructive pulmonary disease (COPD) encompasses any of a group of lower airway diseases that share certain common characteristics. These include increased resistance to air movement, prolongation of the expiratory phase of breathing, and a decrease in the normal elasticity of the lungs. Examples of COPD include emphysema and chronic bronchitis. Causes of COPD include chronic smoking (the primary risk factor), occupational exposure, air pollution, and genetic factors. Symptoms include dyspnea on exertion, chronic cough, and sputum production.

[0014] Neuromuscular diseases (NMD) is a broad term that encompasses numerous diseases and illnesses that impair muscle function directly through intrinsic muscle pathology or indirectly through neuropathology. Some NMD patients are characterized by progressive muscle damage, resulting in inability to walk, wheelchair confinement, difficulty swallowing, respiratory muscle weakness, and ultimately death due to respiratory failure. Neuromuscular disorders can be classified as rapidly and slowly progressive: (i) rapidly progressive disorders, characterized by muscle damage that worsens over months and leads to death within a few years (e.g., amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD) in teenagers); (ii) variable or slowly progressive disorders, characterized by muscle damage that worsens over years and only slightly reduces life expectancy (e.g., limb-girdle, facioscapulohumeral, and myotonic muscular dystrophies). Symptoms of respiratory failure in NMD include: increasing generalized weakness, difficulty swallowing, dyspnea on exertion and at rest, fatigue, drowsiness, morning headache, and difficulty concentrating and mood changes.

[0015] Chest wall disorders are a group of thoracic deformities that result in ineffective connections between the respiratory muscles and the rib cage. These disorders are primarily characterized by restrictive defects and share the potential for long-term hypercapnic respiratory insufficiency. Scoliosis and / or kyphoscoliosis can lead to severe respiratory insufficiency. Symptoms of respiratory insufficiency include: dyspnea on exertion, peripheral edema, orthopnea, recurrent chest infections, morning headache, fatigue, poor quality of sleep, and loss of appetite.

[0016] A range of treatments are available to treat or ameliorate such conditions, and otherwise healthy individuals may also benefit from preventative treatments for respiratory disease, but these suffer from a number of deficiencies.

[0017] 2.2.2 Treatment A variety of therapies are used to treat one or more of the above-mentioned respiratory disorders, including continuous positive airway pressure (CPAP) therapy, non-invasive ventilation (NIV) and invasive ventilation (IV).

[0018] Continuous positive airway pressure (CPAP) therapy has been used in the treatment of obstructive sleep apnea (OSA). Its mechanism of action is that CPAP therapy acts as a pneumatic splint, for example by pushing the soft palate and tongue forward or backward against the posterior oropharyngeal wall, which may prevent the upper airway from closing. Because the treatment of OSA with CPAP therapy may be voluntary, patients may choose not to comply with the treatment if they perceive one or more of the following from the device used to deliver the treatment: uncomfortable, difficult to use, expensive, or aesthetically unappealing.

[0019] Non-invasive ventilation (NIV) provides ventilatory support to a patient through the upper airway to assist in breathing by performing some or all of the respiratory functions and / or to maintain adequate oxygen levels in the body. Ventilatory support is provided through a non-invasive patient interface. NIV is used to treat forms of CSR and respiratory failure such as OHS, COPD, NMD, and chest wall disorders. In some forms, it may improve the comfort and effectiveness of these treatments.

[0020] Invasive ventilation (IV) provides ventilatory support to patients who can no longer breathe effectively on their own and may be provided using a tracheotomy tube. In some forms, the comfort and effectiveness of these treatments may be improved.

[0021] 2.2.3 Treatment system These therapies may be provided by a therapeutic system or device. Such systems and devices may also be used to screen, diagnose, or monitor a disease without treating it.

[0022] The treatment system may include a respiratory pressure treatment device (RPT device), an air circuit, a humidifier, a patient interface, and data management.

[0023] Another form of treatment system is a mandibular repositioning device.

[0024] 2.2.3.1 Patient Interface The patient interface may be used to provide the wearer with an interface to the respiratory appliance, for example by providing airflow to the airway entrance. Airflow may be provided via a mask to the nose and / or mouth, a tube to the mouth, or a tracheotomy tube to the patient's trachea. Depending on the therapy being applied, the patient interface may form a seal, for example with an area of ​​the patient's face, to facilitate gas delivery at a pressure of sufficient dispersion with ambient pressure for therapy to be performed (e.g., at a positive pressure of about 10 cmH2O relative to ambient pressure). In other forms of therapy, such as oxygen delivery, the patient interface may not include a seal sufficient to facilitate delivery of a gas supply to the airway at a positive pressure of about 10 cmH2O.

[0025] Certain other mask systems may be functionally inadequate in the field, for example masks that are purely decorative may not be able to maintain adequate pressure, mask systems used for underwater swimming or diving may be configured to protect against water intrusion from higher external pressures and not maintain internal air at pressures higher than ambient.

[0026] A particular mask may be clinically unsuitable for this technology (eg, if the mask blocks airflow through the nose and only allows airflow through the mouth).

[0027] In certain masks, where the patient must insert part of the mask structure into their mouth and create and maintain a seal via the lips, this may be uncomfortable or impractical in the art.

[0028] Certain masks may be impractical for use while sleeping (eg, when sleeping on one's side in bed with head on a pillow).

[0029] There are several challenges in designing a patient interface: The face has a complex three-dimensional shape. The size and shape of the nose and head vary greatly between individuals. Because the head contains bone, cartilage and soft tissue, different regions of the face respond differently to mechanical forces; i.e., the chin or mandible may move relative to other bones of the skull. The entire head may move throughout the respiratory treatment period.

[0030] These challenges may result in one or more of the following: some masks may be intrusive, aesthetically undesirable, costly, poor fit, difficult to use, and uncomfortable, especially if the wear time is long or the patient is unfamiliar with the system. If the wrong size mask is used, this may lead to poor compliance, poor comfort, and poor patient outcomes. While masks designed specifically for aviators, as part of personal protective equipment (e.g., filter masks), SCUBA masks, or masks for anesthesia administration may be tolerable for their intended use, such masks may be undesirably uncomfortable to wear for extended periods of time (e.g., several hours). Such discomfort may result in poor patient compliance with the treatment. This is especially true if the mask must be worn while sleeping.

[0031] CPAP therapy is highly effective in treating certain respiratory disorders if the patient complies with the therapy. If the mask is uncomfortable or difficult to use, the patient may not comply with the therapy. Because patients are often encouraged to clean their masks regularly, if the mask is difficult to clean (e.g., difficult to assemble or disassemble), the patient may not be able to clean the mask, which may affect patient compliance.

[0032] Masks for other uses (e.g., for aviators) may be unsuitable for use in treating sleep-disordered breathing, and masks designed for use in treating sleep-disordered breathing may be suitable for other uses.

[0033] For these reasons, patient interfaces for CPAP delivery during sleep form a distinct field.

[0034] 2.2.3.1.1 Seal formation structure The patient interface may include a seal-forming structure. Because the patient interface is in direct contact with the patient's face, the shape and configuration of the seal-forming structure may have a direct impact on the effectiveness and comfort of the patient interface.

[0035] The patient interface may be characterized in part according to the design intent of where the seal-forming structure engages the face in use. In one form of the patient interface, the seal-forming structure may include a first sub-portion for forming a seal around the left nostril and a second sub-portion for forming a seal around the right nostril. In one form of the patient interface, the seal-forming structure may include a single element that encloses both nostrils in use. Such a single element may be designed to rest, for example, on the upper lip region and nose bridge region of the face. In one form of the patient interface, the seal-forming structure may include an element that encloses the mouth region in use, for example by forming a seal on the lower lip region of the face. In one form of the patient interface, the seal-forming structure may include a single element that encloses both nostrils and the mouth region in use. These different types of patient interfaces may be known by various names by their manufacturers, such as nasal masks, full face masks, nasal pillows, nasal puffs, and oronasal masks.

[0036] A seal-forming structure that may be effective in one area of ​​a patient's face may be inappropriate in another area due to, for example, different shapes, structures, variability, and sensitive areas of the patient's face. For example, the seal of swim goggles that rests on the patient's forehead may be inappropriate for use on the patient's nose.

[0037] A particular seal-forming structure may be designed for mass production so that one design will fit, be comfortable and effective for a wide range of different face shapes and sizes. To the extent there is a mismatch between the shape of the patient's face and the seal-forming structure of the mass-produced patient interface, one or both may need to be adapted in order to form a seal.

[0038] One type of seal-forming structure extends around the periphery of the patient interface and is intended to seal against the patient's face when force is applied to the patient interface with the seal-forming structure engaging against the patient's face. The seal-forming structure may include an air or fluid filled cushion, or may include a molded or formed surface of a resilient sealing element comprised of an elastomer such as rubber. With this type of seal-forming structure, if the fit is improper, a gap will develop between the seal-forming structure and the face, requiring additional force to press the patient interface against the face to achieve a seal.

[0039] Another type of seal-forming structure uses a thin flap seal located around the periphery of the mask to provide a self-sealing action against the patient's face when positive pressure is applied within the mask. As with the previous type of seal-forming portion, if the fit between the face and the mask is poor, additional force may be required to achieve a seal or the mask may leak. Additionally, if the shape of the seal-forming structure does not match the shape of the patient, the seal-forming portion may fold or buckle during use, causing leakage.

[0040] Other types of seal-forming structures may include friction-fit elements that are inserted into the nostrils, for example, but some patients find these seal-forming parts uncomfortable.

[0041] Another form of seal-forming structure may use adhesives to achieve a seal. Some patients find it inconvenient to constantly apply and remove adhesives from their face.

[0042] A range of patient interface seal forming structures are disclosed in the following patent applications (assigned to ResMed Limited: US Pat. No. 5,393,621; US ​​Pat. No. 5,493,621; and US Pat. No. 5,593,621).

[0043] One form of nasal pillow is found in the Adam line manufactured by Puritan Bennett. Another nasal pillow or nasal puff is the subject of US Pat. No. 5,399,323 (Trimble et al.), assigned to the Puritan-Bennett Corporation.

[0044] ResMed Limited manufactures the following products that use nasal pillows: SWIFT® nasal pillows mask, SWIFT® II nasal pillows mask, SWIFT® LT nasal pillows mask, SWIFT® FX nasal pillows mask, and MIRAGE LIBERTY® full face mask. Examples of nasal pillows masks are described in the following patent applications assigned to ResMed Limited: US Pat. No. 5,399,433 (which describes, among other things, aspects of ResMed Limited's SWIFT® nasal pillows), US Pat. No. 5,399,433 (which describes, among other things, aspects of ResMed Limited's SWIFT® LT nasal pillows), US Pat. No. 5,499,433 (which describes, among other things, aspects of ResMed Limited's MIRAGE LIBERTY® full face mask), and US Pat. No. 5,499,433 (which describes, among other things, aspects of ResMed Limited's SWIFT® FX nasal pillows).

[0045] 2.2.3.1.2 Positioning and stabilization Seal-forming structures in patient interfaces used in positive air therapy experience corresponding forces from the air pressure that disrupt a seal, and therefore a variety of techniques are used to position the seal-forming structures and maintain a seal against the appropriate portion of the face.

[0046] In one technique, adhesives are used, see, for example, US Patent Application Publication US2010 / 0000534, but adhesives can be uncomfortable.

[0047] Another technique involves the use of one or more straps and / or stabilizing harnesses, many of which suffer from one or more of the following problems: poor fit, bulkiness, discomfort and awkwardness.

[0048] 2.2.3.2 Respiratory Pressure Therapy (RPT) Devices Respiratory pressure therapy (RPT) devices may be used individually or as part of a system to deliver one or more of the therapies described above, for example by actuating the device to generate an air delivery flow to an interface to the airway. This air flow may be pressurized. Examples of RPT devices include CPAP devices and mechanical ventilators.

[0049] Air pressure generators are known for a wide range of applications (e.g., industrial-scale ventilation systems). However, air pressure generators for medical applications have specific requirements that cannot be met by more common air pressure generators (e.g., medical equipment reliability requirements, size requirements, and weight requirements). In addition, even devices designed for medical treatment may suffer from deficiencies related to one or more of the following: comfort, noise, ease of use, effectiveness, size, weight, manufacturability, cost, and reliability.

[0050] One example of a special requirement of a particular RPT device is acoustic noise. Table of noise output levels of conventional RPT devices (measured on one sample only at 10cmH2O in CPAP mode using the test method specified in ISO3744).

[0051] [Table 1]

[0052] One known RPT device used to treat sleep-disordered breathing is the S9 Sleep Therapy System (manufactured by ResMed Limited). Another example of an RPT device is a ventilator. Ventilators (e.g., the ResMed Stellar® series of adult and pediatric ventilators) can provide invasive and non-invasive independent breathing support for patients for a range of conditions (including, but not limited to, NMD, OHS, and COPD).

[0053] The ResMed Elisee® 150 ventilator and ResMed VSIII® ventilators can provide invasive and non-invasive dependent respiratory support suitable for adult or pediatric patients for the treatment of multiple conditions. These ventilators provide volumetric and pressure ventilation modes with single or dual limb circuits. RPT devices typically include a pressure generator (e.g., a motorized blower or compressed gas reservoir) and are configured to deliver airflow to the patient's airway. In some cases, the airflow can be delivered at positive pressure to the patient's airway. The outlet of the RPT device is connected via an air circuit to a patient interface as described above.

[0054] A device designer may be presented with a myriad of choices. Often, design criteria conflict, making certain design choices unconventional or unavoidable. Furthermore, the comfort and effectiveness of a particular embodiment may be significantly affected by minor changes in one or more parameters.

[0055] 2.2.3.3 Humidifier Delivery of airflow without humidification can lead to drying of the airway. When a humidifier is used with the RPT device and patient interface, humidified gas is produced, minimizing drying of the nasal mucosa and increasing comfort of the patient airway. Additionally, in cooler climates, the application of warm air to the facial area surrounding the patient interface generally provides more comfort than cool air.

[0056] A range of artificial humidification devices and systems are known, but do not meet the special requirements of medical humidifiers.

[0057] Medical humidifiers are typically used when a patient is sleeping or resting (e.g., in a hospital) to increase the humidity and / or temperature of the air stream relative to the ambient air when necessary. Bedside medical humidifiers may be small. Medical humidifiers may be configured to only humidify and / or heat the air stream delivered to the patient, and not the patient's surroundings. For example, room-based systems (e.g., saunas, air conditioners, or evaporative coolers) may also humidify the air breathed into the patient's body, but these systems also humidify and / or heat the entire room, which may be uncomfortable for occupants. Additionally, medical humidifiers may have more stringent safety constraints than industrial humidifiers.

[0058] Although a number of medical humidifiers are known, such medical humidifiers may suffer from one or more deficiencies, i.e., some of such medical humidifiers provide inadequate humidification and others are difficult or inconvenient for the patient to use.

[0059] 2.2.3.4 Data Management For clinical reasons, data may be obtained to determine whether a patient prescribed respiratory treatment is "compliant" (e.g., whether the patient complies with one or more "compliance rules" with their RPT device). One example of a compliance rule for CPAP treatment may require a patient to use the RPT device for at least 4 hours per night for at least 21 days out of 30 consecutive days to be considered compliant. To determine patient compliance, a provider of the RPT device (e.g., a healthcare provider) may manually obtain data describing the patient's treatment with the RPT device, calculate a usage rate over a period of time, and compare this to the compliance rules. Once the healthcare provider determines that the patient has used their RPT device in accordance with the compliance rules, the healthcare provider may notify a third party that the patient is compliant.

[0060] There may be other aspects of a patient's care that would benefit from communication of treatment data to third parties or external systems.

[0061] Existing processes for communicating and managing such data can be one or more of: costly, time consuming, and error prone.

[0062] 2.2.3.5 Mandibular repositioning Mandibular repositioning devices (MRDs) or mandibular advancement devices (MADs) are a treatment option for sleep apnea and snoring. They are adjustable oral appliances available from dentists or other suppliers that hold the mandible (lower jaw) in an anterior position during sleep. MRDs are removable devices that are inserted into the oral cavity before the patient sleeps and removed afterwards. As such, MRDs are not designed for full-time wear. MRDs may be custom made or manufactured in standard forms and include bite impression sites designed to fit the patient's teeth. This mechanical protrusion from the mandible expands the space behind the tongue and applies tension on the pharyngeal walls to reduce airway collapse and reduce palate vibration.

[0063] In certain examples, the mandibular advancement device may include an upper splint intended to engage or mate with the maxilla or teeth on the maxilla, and a lower splint intended to engage or mate with the maxilla or teeth on the mandible. The upper and lower splints are laterally connected to each other via a pair of connecting rods that are fixed symmetrically on the upper and lower splints.

[0064] In such a design, the length of the connecting rod is selected so that the mandible is held in an anterior position when the MRD is placed in the patient's mouth. The length of the connecting rod can be adjusted to vary the level of protrusion of the mandible. The dentist can determine the level of protrusion required for the mandible, which in turn determines the length of the connecting rod.

[0065] Some MRDs are configured to push the mandible forward relative to the maxilla, while others, such as the ResMed Narval CC® MRD, are designed to hold the mandible in an anterior position. The device also reduces or minimizes dental and temporomandibular joint (TMJ) side effects. As such, the device is configured to minimize or avoid any movement of one or more of the teeth.

[0066] 2.2.3.6 Ventilation technology Some forms of treatment systems may include a vent to push out exhaled carbon dioxide, which may allow gas flow from an interior space of the patient interface (e.g., a plenum chamber) to an exterior of the patient interface (e.g., the surroundings).

[0067] The vent may include an orifice through which gas may flow when the mask is in use. Many such vents are noisy. Others may become blocked when in use, resulting in insufficient pumping. Some vents may disrupt sleep for the patient 1000 and bed companion 1100, for example, due to noise or airflow concentration.

[0068] ResMed Limited has developed several improved mask ventilation technologies, see: US Patent Nos. 5,993, 6,143, 5,152, 5,166, 5,171, 5,182, 5,193, 6,196, 7,146, 7,177, 7,189, 8,196, 9,103, 9,104, 9,105, 9, Conventional mask noise table (ISO17510-2:2007, 10cmH2O pressure at 1m)

[0069] [Table 2]

[0070] (*Measured one sample at 10cmH2O in CPAP mode using the test method specified in ISO3744) The sound pressure values ​​of various objects are listed below.

[0071] [Table 3]

[0072] 2.2.4 Screening, diagnostic and monitoring systems Polysomnography (PSG) is a conventional system for diagnosing and monitoring cardiopulmonary diseases, which typically requires expert clinical staff for system application. In PSG, typically 15-20 contact sensors are placed on the human body to record various body signals (e.g., electroencephalography (EEG), electrocardiography (ECG), electrooculography (EOG), electromyography (EMG)). For PSG of sleep-disordered breathing, patients need to be observed for two nights in a specialized hospital; the first night is purely for diagnosis, and the second night is required for titration of treatment parameters by the clinician. Therefore, PSG is expensive and inconvenient. Screening / diagnosis / monitoring of sleep-disordered breathing is particularly unsuitable at home.

[0073] In general, screening and diagnosis are the identification of disease by signs and symptoms of the disease. Screening usually produces a true / false result indicating whether or not a patient's SDB warrants further investigation, whereas diagnosis often produces clinically actionable information. Screening and diagnosis tend to be one-time procedures, whereas monitoring the progression of the disease can continue indefinitely. Some screening / diagnostic systems are adapted for screening / diagnosis only, while some can be used for monitoring as well.

[0074] A clinical expert may adequately screen, diagnose, or monitor a patient based on visual observation of the PSG signal. However, there are situations where a clinical expert is not available or cannot be paid. Different clinical experts may have different opinions about a patient's condition. Furthermore, a given clinical expert may apply different criteria at different times. [Prior art documents] [Patent documents]

[0075] [Patent Document 1] U.S. Pat. No. 4,944,310 [Patent Document 2] U.S. Patent No. 6,532,959 [Patent Document 3] International Publication No. 1998 / 004310 [Patent Document 4] International Publication No. 2006 / 074513 [Patent Document 5] International Publication No. 2010 / 135785 [Patent Document 6] U.S. Pat. No. 4,782,832 [Patent Document 7] International Publication No. 2004 / 073778 [Patent Document 8] US Patent Application Publication No. 2009 / 0044808 [Patent Document 9] International Publication No. 2005 / 063328 [Patent Document 10] International Publication No. 2006 / 130903 [Patent Document 11] International Publication No. 2009 / 052560 [Patent Document 12] International Publication No. 1998 / 034665 [Patent Document 13] International Publication No. 2000 / 078381 [Patent Document 14] U.S. Patent No. 6,581,594 [Patent Document 15] US Patent Application Publication No. 2009 / 0050156 [Patent Document 16] US Patent Application Publication No. 2009 / 0044808 Summary of the Invention [Means for solving the problem]

[0076] 3. Brief description of the technology The present technology relates to the provision of medical devices for use in screening, diagnosing, monitoring, ameliorating, treating or preventing respiratory disease, which medical devices have one or more of improved comfort, cost, effectiveness, ease of use and manufacturability.

[0077] A first aspect of the present technology relates to devices for use in screening, diagnosing, monitoring, ameliorating, treating or preventing respiratory disease.

[0078] Another aspect of the present technology relates to methods for use in the screening, diagnosis, monitoring, amelioration, treatment or prevention of respiratory disorders.

[0079] One aspect of certain forms of the present technology is to provide methods and / or devices that improve patient compliance with respiratory treatment.

[0080] Another aspect of the present technology relates to a patient interface that may include: a plenum chamber, a seal-forming structure, and a positioning and stabilizing structure. The patient interface may further include a venting structure. The patient may be further configured to expose the patient's oral cavity, or, if the seal-forming structure is configured to seal around the patient's nose and mouth, the patient interface may be further configured to allow the patient to breathe from the atmosphere through their oral cavity in the absence of pressurized air flow through the plenum chamber inlet port.

[0081] Aspects of the present technology relate to a patient interface. The patient interface may include a plenum chamber pressurizable to a therapeutic pressure, a seal-forming structure constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, a positioning and stabilizing structure providing a force to hold the seal-forming structure in a therapeutically effective position on the patient's head, and a venting structure for allowing continuous flow of gases exhaled by the patient from inside the plenum chamber to the atmosphere. The patient interface is configured to leave the patient's mouth exposed during treatment. The seal-forming structure includes two lateral support regions, each disposed on a lateral extreme side of the seal-forming structure, and a middle region disposed between the lateral support regions. A hole passes through the middle region, and the lateral support region is thicker than the middle region.

[0082] In any embodiment of any aspect of the preceding paragraph: (a) the seal-forming structure may include two mid-lateral regions, each of which is laterally outward from and adjacent to the medial region and medially inward from the lateral support region. (b) the seal-forming structure may include two corner regions configured to engage the patient's face at the alar nasal nadir region, the corner regions being located where the intermediate region, the alar nadir region, and the lateral support region converge; (c) the hole portion may be divided into two nostril openings by a bridge portion, the bridge portion being relaxed in the undeformed state; (d) the bridge portion may be thicker than the intermediate region; (e) the nostril openings may be surrounded by the intermediate region and the bridge portion; (f) the seal-forming structure may be constructed of a flexible material; (g) the flexible material may be silicone; (h) the plenum chamber may include an inner surface and an outer surface, the inner surface may be arranged to be at a therapeutic pressure in use, and the shell outer surface may be arranged to be at ambient pressure in use; (h) the plenum chamber may be arranged to be at ambient pressure. than Approximately 30cmH2O Less than(i) the plenum chamber may be constructed from a rigid plastic material, (j) the plenum chamber may be constructed from a transparent material, (k) the vent structure may include a plurality of vent holes formed in the plenum chamber, (l) the intermediate region may extend to a front side of the seal-forming structure that does not contact the patient in use, (m) the intermediate region may extend to a front side of the seal-forming structure of an upper portion of the seal-forming structure, (n) the intermediate region may extend to a front side of the seal-forming structure of a lower portion of the seal-forming structure, (o) the positive lateral region may extend to a front side of the seal-forming structure that does not contact the patient in use, (p) the positive lateral region may extend to a front side of the seal-forming structure that does not contact the patient in use, (p) the positive lateral region may extend to a front side of the seal-forming structure that does not contact the patient in use, (p) the positive lateral region may extend to a front side of the seal-forming structure of a lower portion of the seal-forming structure ... of a (q) the positive lateral region may extend to the front of the seal-forming structure below the seal-forming structure; (r) the bridge portion may be curved as it approaches the plenum chamber to avoid contact with the patient's bridge of the nose in use; (s) the intermediate region may be disposed between the positive lateral regions such that the positive lateral regions are separated from one another; (t) the intermediate region and the positive lateral region may be disposed between the lateral support regions such that the lateral support regions are separated from one another; and / or (u) the seal-forming structure may be shaped and dimensioned so as not to engage the patient's nose above the nasal tip.

[0083] Another aspect of the present technology relates to a patient interface that may include: ambient air pressure than At least 6cmH2O expensivea plenum chamber, pressurizable to a therapeutic pressure, said plenum chamber including a plenum chamber inlet port sized and configured to receive an airflow at the therapeutic pressure for breathing of the patient; a seal-forming structure constructed and arranged to form a seal against an area of ​​the patient's face surrounding an entrance to the patient's airways, said seal-forming structure having holes therein whereby an airflow at said therapeutic pressure is delivered to at least an entrance to the patient's nares, the seal-forming structure constructed and arranged to, in use, maintain said therapeutic pressure within the plenum chamber throughout the patient's respiratory cycle; and a positioning and stabilizing structure providing a force to hold the seal-forming structure in a therapeutically effective position on the patient's head, the positioning and stabilizing structure including a tie, the tie constructed and arranged such that, in use, at least a portion of the tie rests against an area of ​​the patient's head above an upper ear base point of the patient's head. and a venting structure that allows continuous flow of patient exhaled gases from within the plenum chamber to the surroundings, said venting structure being sized and shaped to maintain a therapeutic pressure within the plenum chamber in use; the patient interface is configured to leave the patient's mouth exposed during treatment, the plenum chamber further including a pair of plenum chamber connectors, each plenum chamber connector being disposed on each lateral side of the plenum chamber, the positioning and stabilizing structure further including a tube having a pair of ends, the positioning and stabilizing structure further including a clip joined at each of the ends to a clip overmold, the clip overmold being joined to the tube at a corresponding one of the ends, each of the ends being releasably connected to a corresponding plenum chamber connector by engagement of the clip with the corresponding plenum chamber connector.

[0084] In any embodiment of any of the aspects of any of the preceding paragraphs: (a) the tube may be constructed from a first silicone material, the clip overmolds may each be constructed from a second silicone material different from the first silicone material, and the clips may each be constructed from a first plastic material that is relatively more rigid than the first silicone material and the second silicone material; (b) the first silicone material may not be capable of bonding to the first plastic material; (c) the first silicone material may not be capable of chemically bonding to the first plastic material; (d) the second silicone material may not be capable of chemically bonding to the first silicone material and the first plastic material; (e) the tube may be constructed from a single homogenous piece of the first silicone material; (f) the clip overmolds may each be constructed from a single homogenous piece of the second silicone material; (g) the clips may each be constructed from a single homogenous piece of the first plastic material; and (h) the plenum chamber is , and a second plastic material; (i) the second plastic material and the first plastic material may be the same; (j) the second plastic material and the first plastic material may be different; (k) the plenum chamber connectors may each include a pair of slots so that the plenum chamber connectors are deformable and have a reduced cross-section; (l) the plenum chamber connectors may each be configured to be connected to a corresponding one of the clips with a snap-fit; (m) each of the clips and each of the clip overmolds may be positioned completely within the corresponding end of the tube; (n) the plenum chamber connectors may be positioned completely within the corresponding end of the tube when the end of the tube is connected to the corresponding one of the plenum chamber connectors; and / or (o) each of the plenum chamber connectors may include a chamfered edge and each of the clips may include a notch, where the chamfered edge and the corresponding notch are configured to engage with a snap-fit.

[0085] Another aspect of one form of the present technology is a patient interface that is molded or otherwise constructed with a peripheral shape that is complimentary to the shape of the intended wearer.

[0086] One aspect of the present technology is a manufacturing method.

[0087] One aspect of certain forms of the present technology is a medical device that is easy to use, for example, by individuals without medical training, individuals with limited dexterity or insight, or individuals with limited experience in using medical devices of this type.

[0088] One aspect of one form of the present technology is a portable RPT device that a person can carry with them (eg, around the home).

[0089] One aspect of one form of the present technology is a patient interface that can be cleaned at the patient's home, for example with soapy water, without the need for special cleaning equipment.One aspect of one form of the present technology is a patient interface that can be cleaned at the patient's home, for example with soapy water, without the need for special cleaning equipment.

[0090] The described methods, systems, devices and apparatus may be implemented to enable improved functionality in a processor (e.g., a processor of a special purpose computer, a respiratory monitor and / or a respiratory treatment device). Additionally, the described methods, systems, devices and apparatus enable advances in the art of automated management, monitoring and / or treatment of respiratory conditions (e.g., sleep disordered breathing).

[0091] Of course, some of the above aspects may form sub-aspects of the present technology, and various one of the sub-aspects and / or aspects may be combined in various ways to form further aspects or sub-aspects of the present technology.

[0092] Other features of the present technology will become apparent in light of the information contained in the following detailed description, abstract, drawings, and claims. [Brief description of the drawings]

[0093] 4. Brief Description of the Drawings The present technology is illustrated by way of one non-limiting example in the accompanying drawings, in which like reference symbols include like elements: 4.1 Treatment system [Figure 1A] The system is shown to include a patient 1000 wearing a patient interface 3000. The system takes the form of nasal pillows and receives air at positive pressure supplied by an RPT device 4000. The air from the RPT device 4000 is humidified by a humidifier 5000 and travels along an air circuit 4170 to the patient 1000. A bed companion 1100 is also shown. The patient is sleeping in a supine sleep position. [Figure 1B] A system is shown including a patient 1000 wearing a patient interface 3000. The system takes the form of a nasal mask and receives air at positive pressure supplied by an RPT device 4000. Air from the RPT device is humidified by a humidifier 5000 and travels along an air circuit 4170 to the patient 1000. [Figure 1C] The system includes a patient 1000 wearing a patient interface 3000. The patient interface 3000 takes the form of a full face mask and receives a positive pressure air supply from an RPT device 4000. Air from the RPT device is humidified by a humidifier 5000 and travels along an air circuit 4170 to the patient 1000. The patient is sleeping in a lateral sleep position. 4.2 Respiratory System and Facial Anatomy [Figure 2A] An outline of the human respiratory system is shown, including the nasal and oral cavities, larynx, vocal folds, esophagus, trachea, bronchi, lungs, alveolar sacs, heart and diaphragm. [Figure 2B] FIG. 1 is a diagram of the human upper respiratory tract including the nasal cavity, nasal bones, lateral nasal cartilages, greater alar cartilage, nostrils, upper lip, lower lip, larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal cords, esophagus, and trachea. [Figure 2C] FIG. 1 is a front view of a face including several features of the surface anatomy including upper lip, upper lip vermilion, lower lip vermilion, lower lip, mouth width, medial canthus, alae of the nose, nasolabial folds, and corners of the mouth. The directions of superior, inferior, radially inward, and radially outward are also given. [Figure 2D]FIG. 1 is a lateral view of the head including several features of the surface anatomy including the glabella, serion, nasal tip, subnasal point, upper lip, lower lip, supramenton, nasal ridge, alar crest, superior and inferior temporal points. The directions of superior and inferior, and anterior and posterior are also given. [Figure 2E] FIG. 1 is a further lateral view of the head, with the approximate locations of the Frankfort horizontal and nasolabial angle noted. The coronal plane is also noted. [Figure 2F] A bottom view of the nose including several features including nasolabial fold, lower lip, upper lip vermilion, nostrils, subnasal point, columella, nasal tip, nostril axis and midsagittal plane. [Figure 2G] FIG. 2 is a side view of the superficial features of the nose. [Figure 2H] Shown are the subcutaneous structures of the nose including the lateral nasal cartilages, nasal septum cartilage, greater alar cartilage, lesser alar cartilage, nasal sesamoid cartilage, nasal bones, epidermis, adipose tissue, frontal process of the maxilla and fibro-adipose tissue. [Figure 2I] The mid-nasal incision is shown approximately a few millimeters from the midsagittal plane, with particular attention to the nasal septal cartilage and the medial crus of the greater alar cartilage. [Figure 2J] FIG. 1 is a frontal bony view of the skull including the frontal, nasal and cheekbones, with the nasal turbinates shown along with the maxilla and mandible. [Figure 2K] Side view of the skull with the outline of the head surface and some muscles. The following bones are shown: frontal, sphenoid, nasal, zygomatic, maxilla, mandible, parietal, temporal and occipital. The mental protuberance is shown. The following muscles are shown: digastric, masseter, sternocleidomastoid and trapezius. [Figure 2L] Shown is the anterolateral aspect of the nose. 4.3 Patient Interface [Figure 3A] 1 shows a patient interface in the form of a nasal mask in accordance with one form of the present technology. [Figure 3B] 3C is a schematic cross-sectional view of the structure cut at a point, with the outward normal at this point shown, and the curvature at this point having a positive sign and a relatively large magnitude compared to the magnitude of curvature shown in 3C. [Figure 3C]3B is a schematic cross-sectional view of the structure cut at a point, with the outward normal at this point shown, and the curvature at this point having a positive sign and a relatively small magnitude compared to the magnitude of the curvature shown in FIG. [Figure 3D] 1 is a schematic cross-sectional view of a structure cut at a point, where the outward normal is shown and the curvature value at this point is zero. [Figure 3E] 3C is a schematic cross-sectional view of the structure cut at a point, where the outward normal is shown, and the curvature at this point has a negative sign and a relatively small magnitude compared to the magnitude of curvature shown in FIG. [Figure 3F] 3C is a schematic cross-sectional view of the structure cut at a point, where the outward normal is shown, and the curvature at this point has a negative sign and a relatively large magnitude compared to the magnitude of curvature shown in FIG. [Figure 3G] 1 shows a mask cushion including two pillows, the outer surface of the cushion is shown, the edge of the surface is shown, and the dome region and saddle region are shown. [Figure 3H] 1 shows a cushion for a mask. The outer surface of the cushion is illustrated. The edge of the surface is illustrated. The path on the surface between points A and B is illustrated. The straight line distance between A and B is illustrated. Two saddle regions and a dome region are illustrated. [Figure 3I] The surface of a structure is shown, with a one-dimensional hole drilled into it. The planar curves shown form the boundary of the one-dimensional hole. [Figure 3J] FIGURE 3D is a cross-sectional view through the structure of Figure 3I.The surfaces shown bound a two-dimensional hole in the structure of Figure 3I. [Figure 3K] 3I includes a two-dimensional hole and a one-dimensional hole, and the surfaces bounding the two-dimensional hole in the structure of FIG. [Figure 3L] 1 shows a mask with an inflatable bladder as a cushion. [Figure 3M] 3L is a cross-sectional view of the mask of FIG. 3L showing the inner surface of the bladder, which bounds the two-dimensional hole in the mask. [Figure 3N] 3D shows a further cross section through the mask of FIG. 3L, with the interior surface also shown. [Figure 3O] Demonstrates the left hand rule. [Figure 3P] Demonstrates the right-hand rule. [Figure 3Q] 1 shows the left ear including the left ear helix. [Figure 3R] 1 shows the right ear including the right ear helix. [Figure 3S] Shown is a right-handed spiral. [Figure 3T] FIG. 13 is a diagram of a mask including the signature of the twist of the space curve defined by the edges of the sealing membrane in different regions of the mask. [Figure 3U] A diagram of the plenum chamber 3200 showing the midsagittal plane and the central contact plane. [Figure 3V] A posterior view of the plenum chamber of Figure 3U. Directions in the figure are perpendicular to the central contact plane. In Figure 3V, the midsagittal plane bisects the plenum chamber into a left hand side and a right hand side. [Figure 3W] FIG. 3V is a cross-sectional view through the plenum chamber of FIG. 3V, where the cross-section is taken in the midsagittal plane shown in FIG. The "mid-contact" plane is illustrated. The mid-sagittal plane is perpendicular to the mid-sagittal plane. The orientation of the mid-sagittal plane corresponds to the orientation of the tendon 3210. The tendon 3210 rests on the mid-sagittal plane and only contacts the cushion of the plenum chamber at two points on the mid-sagittal plane (i.e., superior point 3220 and inferior point 3230). Depending on the geometry of the cushion in this region, the mid-contact plane may contact both the superior and inferior points. [Figure 3X] The plenum chamber 3200 of FIG. 3U is shown in a use position on the face. The mid-sagittal plane of the plenum chamber 3200 generally coincides with the mid-sagittal plane of the face when the plenum chamber is in the use position. The central contact plane generally corresponds to the "face of the face" when the plenum chamber is in the use position. In FIG. 3X, the plenum chamber 3200 is of a nasal mask, with the upper point 3220 resting approximately on the cerion and the lower point 3230 resting on the upper lip. 4.4 RPT Device [Figure 4A]1 shows an RPT device in accordance with one form of the present technology. [Figure 4B] FIG. 4 is a schematic diagram of an air pressure path of an RPT device in accordance with one form of the present technology. Upstream and downstream directions are shown relative to the blower and patient interface. Regardless of the actual flow direction at any particular moment, the blower is defined as being upstream of the patient interface, and the patient interface is defined as being downstream of the blower. Items disposed in the air pressure path between the blower and the patient interface are downstream of the blower and upstream of the patient interface. 4.5 Humidifier [Figure 5A] FIG. 1 shows an isometric view of a humidifier in accordance with one form of the present technology. [Figure 5B] Shown is an isometric view of a humidifier in accordance with one form of the present technology, showing the humidifier reservoir 5110 removed from the humidifier reservoir dock 5130. [Figure 5C] FIG. 4.6 Respiration waveforms [Figure 6] A model of a typical human respiratory waveform during sleep is shown. 4.7 Patient interface using this technology [Figure 7] FIG. 14 is a front side view from a superior position of a patient interface according to an embodiment of the present technology as worn by a patient. [Figure 8] FIG. 13 is a front view of a patient interface according to an embodiment of the present technology as worn by a patient. [Figure 9] FIG. 14 is a top view of a patient interface according to an embodiment of the present technology as worn by a patient. [Figure 10] FIG. 13 is a side view of a patient interface according to an embodiment of the present technology as worn by a patient. [Figure 11] FIG. 14 is a front side view from a superior position of a patient interface according to an embodiment of the present technology as worn by a patient. [Figure 12] FIG. 13 is a front view of a patient interface according to an embodiment of the present technology. [Figure 13]FIG. 13 is a front side view from a superior position of a patient interface according to an embodiment of the present technology. [Figure 14] FIG. 13 is a posterior view of a patient interface according to an embodiment of the present technology. [Figure 15] FIG. 13 is a top view of a patient interface according to an embodiment of the present technology. [Figure 16] FIG. 13 is a front side view from a superior position with a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 17] FIG. 13 is a top view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 18] FIG. 13 is an underside view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 19] FIG. 13 is a rear view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 20] FIG. 13 is a front view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 21] FIG. 13 is a lateral view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 22] FIG. 13 is a posterolateral view from a superior position with a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 23] FIG. 13 is a front side view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 24] FIG. 13 is a front view of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Diagram 25] FIG. 13 is a rear view of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 26] FIG. 13 is a top view of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 27] FIG. 13 is an underside view of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 28] FIG. 13 is a posterolateral view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 29] FIG. 13 is a front side view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 30] FIG. 13 is a top view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 31] FIG. 13 is an underside view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 32] FIG. 13 is a rear view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 33] FIG. 13 is a front view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 34] FIG. 13 is a lateral view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 35] FIG. 13 is a front side view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Diagram 36] FIG. 13 is a posterolateral view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 37] FIG. 13 is a front view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 38] FIG. 13 is a rear view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 39] FIG. 13 is a lateral view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 40] FIG. 13 is an underside view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 41] FIG. 13 is a front side view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 42]FIG. 13 is a top view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Diagram 43] FIG. 13 is a front side view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Diagram 44] FIG. 13 is a posterolateral view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Diagram 45] FIG. 13 is a front view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 46] FIG. 13 is a rear view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 47] FIG. 13 is a lateral view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 48] FIG. 13 is an underside view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 49] FIG. 13 is a front side view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 50] FIG. 13 is a top view of a seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 51] FIG. 13 is a front side view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 52] FIG. 13 is a posterolateral view from an elevated position of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Diagram 53] FIG. 54 is a front reference view for a cross section taken through line 54-54 of a seal-forming structure and plenum chamber for a patient interface according to an embodiment of the present technology. [Figure 54] A detailed cross-sectional view of a plenum chamber taken through line 54-54 of Figure 53 in accordance with an embodiment of the present technology. [Figure 55]FIG. 13 is an exploded front view of a plenum chamber disconnected from a conduit and seal-forming structure for a patient interface according to an embodiment of the present technology. [Figure 56] A front reference view of a cross section taken through lines 57-57 and 60-60 of a seal-forming structure and a plenum chamber connected to a conduit for a patient interface according to an embodiment of the present technology. [Figure 57] FIG. 57 is a detailed cross-sectional view of a plenum chamber connector and conduit connected together in accordance with one embodiment of the present technology, taken through line 57-57 in FIG. [Figure 58] FIG. 13 is a perspective view of a conduit clip and clip overmold according to an embodiment of the present technology. [Figure 59] FIG. 58 is a cross-sectional view of the conduit from FIG. 57. [Figure 60] 57 is a cross-sectional view through the conduit into the plenum chamber taken through line 60-60 of FIG. 56. [Figure 61] FIG. 13 is a perspective view of a plenum chamber and a plenum chamber connector according to an embodiment of the present technology. [Figure 62] FIG. 13 is a front view of a seal-forming structure and plenum chamber for a patient interface, without a vent insert in the vent insert opening, according to an embodiment of the present technology. [Figure 63] FIG. 13 is a front view of a seal-forming structure and plenum chamber for a patient interface including a vent insert in a vent insert opening according to an embodiment of the present technology. [Figure 64] FIG. 13 is a cross-sectional view through a plenum chamber of a patient interface in accordance with an embodiment of the present technology. [Figure 65] FIG. 13 is a cross-sectional view through a plenum chamber of a patient interface in accordance with an embodiment of the present technology. [Figure 66] FIG. 13 is a top view of a patient interface according to an embodiment of the present technology. [Figure 67] FIG. 17 is a cross-sectional view showing the inside of the seal-forming structure according to an embodiment of the present technology shown in FIG. [Figure 68] FIG. 30 is a cross-sectional view showing the inside of the seal-forming structure according to an embodiment of the present technology shown in FIG. 29 . [Figure 69] FIG. 38 is a cross-sectional view showing the inside of the seal-forming structure according to an embodiment of the present technology shown in FIG. [Figure 70] FIG. 46 is a cross-sectional view showing the inside of the seal-forming structure according to an embodiment of the present technology shown in FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0094] 5 Detailed Description of the Embodiments of the Present Technology Before describing the present technology in further detail, it should be understood that the present technology is not limited to the specific embodiments described herein, which may vary. It should also be understood that the terminology used in the present disclosure is for the purpose of describing the specific embodiments described herein, and is not intended to be limiting.

[0095] The following description is provided in conjunction with various embodiments that may share one or more common characteristics and / or features. It should be understood that one or more features of any one embodiment may be combined with one or more features of another embodiment or other embodiments. In addition, any single feature or combination of features in any of these embodiments may constitute an additional embodiment.

[0096] 5.1 Treatment In one form, the present technology includes a method of treating a respiratory disorder, the method including the step of applying positive pressure to an entrance to the airways of a patient 1000.

[0097] In certain embodiments of the present technology, a supply of air at positive pressure is provided to the patient's nasal passages via one or both nostrils.

[0098] In certain embodiments of the present technology, mouth breathing is restricted, limited or prevented.

[0099] 5.2 Treatment system In one form, the present technology includes an apparatus or device for the treatment of respiratory disorders. The apparatus or device may include an RPT device 4000 that supplies pressurized air to a patient 1000 via an air circuit 4170 to a patient interface 3000.

[0100] 5.3 Patient Interface A non-invasive patient interface 3000 according to one aspect of the present technology includes the following functionalities: a seal-forming structure 3100, a plenum chamber 3200, a positioning and stabilizing structure 3300, a vent 3400, a form of connection port 3600 for connection to an air circuit 4170, and a forehead support 3700. In some forms, the functionalities may be provided by one or more physical components. In some forms, one physical component may provide one or more functionalities. In use, the seal-forming structure 3100 is positioned to surround an entrance to the patient's airway to facilitate the supply of air at positive pressure to the airway.

[0101] If the patient interface cannot comfortably deliver a minimum level of positive pressure to the airway, the patient interface may be unsuitable for respiratory pressure therapy.

[0102] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide an air supply at a positive pressure of at least 6 cmH2O relative to ambient.

[0103] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide an air supply at a positive pressure of at least 10 cmH2O relative to ambient.

[0104] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide an air supply at a positive pressure of at least 20 cmH2O relative to ambient.

[0105] 5.3.1 Seal formation structure In one form of the present technology, the seal-forming structure 3100 provides a target seal-forming area and may further provide a cushioning function. The target seal-forming area is the area where a seal may occur in the seal-forming structure 3100. The area where a seal actually occurs (i.e., the actual sealing surface) may vary from patient to patient in a given treatment session from day to day depending on a range of factors (e.g., placement of the patient interface on the face, tension in the positioning and stabilizing structure, and the shape of the patient's face).

[0106] In one form, the target seal-forming area is located on an exterior surface of the seal-forming structure 3100 .

[0107] In certain forms of the present technology, the seal-forming structure 3100 is constructed from a biocompatible material (eg, silicone rubber).

[0108] A seal-forming structure 3100 in accordance with the present technology may be constructed from a material that is soft, flexible and resilient (eg, silicone).

[0109] In certain forms of the present technology, a system is provided that includes more than one seal-forming structure 3100. Each seal-forming structure 3100 is configured to accommodate a different size and / or shape range. For example, the system may include one form of seal-forming structure 3100 suitable for large head sizes but not small head sizes, and another suitable for small head sizes but not large head sizes.

[0110] 5.3.1.1 Sealing mechanism In one form, the seal-forming structure includes a sealing flange that employs a pressure-assisted sealing mechanism. In use, the sealing flange can readily respond to positive system pressure within the plenum chamber 3200 to act on its underside to form a tight sealing engagement with a surface. The pressure-assisted mechanism can work in conjunction with elastic tension in the positioning and stabilizing structure.

[0111] In one form, the seal-forming structure 3100 includes a sealing flange and a support flange. The sealing flange includes a relatively thin member having a thickness of less than about 1 mm (e.g., about 0.25 mm to about 0.45 mm) that extends around the edge length of the plenum chamber 3200. The support flange may be relatively thicker than the sealing flange. The support flange is disposed between the sealing flange and the periphery of the plenum chamber 3200 and extends around at least a portion of the edge length. The support flange is or includes a spring-like element and functions to support the sealing flange against buckling in use.

[0112] In one form, the seal-forming structure may include a compression seal or gasket seal that is constructed and arranged such that, in use, it is in a compressed state due to, for example, elastic tension in the positioning and stabilizing structure.

[0113] In one form the seal-forming structure includes a tension part which, in use, is held taut, for example by an adjacent region of a sealing flange.

[0114] In one form the seal-forming structure includes an area having a sticky or adhesive surface.

[0115] In certain forms of the present technology, the seal-forming structure may include one or more of a pressure-assisted sealing flange, a compression seal, a gasket seal, a tension section, and a section having a sticky or adhesive surface.

[0116] 5.3.1.2 Nasal bridge or nasal ridge area In one form, the non-invasive patient interface 3000 includes a seal-forming structure which, in use, forms a seal on the nasal bridge or nasal ridge region of the patient's face.

[0117] In one form, the seal-forming structure includes a saddle-like region constructed to form a seal over the nasal bridge or nasal ridge region of the patient's face in use.

[0118] 5.3.1.3 Upper lip area In one form, the non-invasive patient interface 3000 includes a seal-forming structure that, in use, forms a seal over the upper lip area (ie, upper lip) of the patient's face.

[0119] In one form, the seal-forming structure includes a saddle-shaped region constructed to form a seal over the upper lip region of the patient's face in use.

[0120] 5.3.1.4 Jaw area In one form, the non-invasive patient interface 3000 includes a seal-forming structure which, in use, forms a seal over the chin area of ​​the patient's face.

[0121] In one form, the seal-forming structure includes a saddle-like region constructed to form a seal over the chin region of the patient's face in use.

[0122] 5.3.1.5 Frontal Area In one form, the seal-forming structure forms a seal on the forehead region of the patient's face when in use, hi such a form, the plenum chamber may cover the eye when in use.

[0123] 5.3.1.6 Nasal pillow In one form, the seal-forming structure of the non-invasive patient interface 3000 includes a pair of nasal puffs or nasal pillows, each constructed and arranged to form a seal with a respective nostril of the patient's nose.

[0124] A nasal pillow according to one aspect of the present technology includes a frustum of a cone. At least a portion of the frustum forms a seal over the underside of the patient's nose, the stalk, and a flexible region on the underside of the frustum, connecting the frustum to the stalk. Additionally, the structure to which the nasal pillows of the present technology are connected includes a flexible region adjacent the base of the stalk. The flexible region may function to facilitate a universal joint structure. The universal joint structure accommodates both the displacement and angle of the frustum of the cone and the relative movement of the structure to which the nasal pillows are connected. For example, the frustum of the cone may be displaced axially towards the structure to which the stalk is connected.

[0125] 5.3.1.7 Nasal Cradle 16-28 and 67 show a seal-forming structure 3100 according to a first example of the present technology. 22-28 show a seal-forming structure 3100 and a plenum chamber 3200, which will be described in more detail below. 29-36 and 68 show a seal-forming structure 3100 according to a second example of the present technology. 35 and 36 show a seal-forming structure 3100 and a plenum chamber 3200, which will be described in more detail below. 37-44 and 69 show a seal-forming structure 3100 according to a third example of the present technology. 43 and 44 show a seal-forming structure 3100 and a plenum chamber 3200, which will be described in more detail below. 45-52 and 70 show a seal-forming structure 3100 according to a fourth example of the present technology. 51 and 52 show a seal-forming structure 3100 and a plenum chamber 3200, which will be described in more detail below. As can be seen from these figures, the different examples vary in size and shape, with each variation intended to provide an optimal fit for patients with different nose and face shapes and sizes. Figures 16-21, 29-34, 37-42 and 45-50 include dashed lines defining boundaries of regions of different thickness, it should be understood that these are nominal boundaries only and not actual configurations.

[0126] The four examples of the seal-forming structure 3100 described in the above paragraphs may be considered as nasal cradle cushions, intended to provide a flow of pressurized gas to the patient's nares by sealing against at least the underside of the patient's nose. The exemplary seal-forming structure 3100 engages the patient's face below the bridge of the nose, and in some examples, depending on the size and shape of the patient's nose, may engage the patient's nose below the nasal tip. In other words, for example, the seal-forming structure 3100 may be structured to not engage the patient's nose above the nasal tip. The exemplary seal-forming structure 3100 also engages the patient's face above at least the upper vermilion lip. Thus, the exemplary seal-forming structure 3100 may seal against the patient's upper lip in use. Additionally, the patient's mouth remains exposed by the seal-forming structure 3100 of the illustrated examples, so the patient may be able to breathe freely (i.e., directly to the atmosphere) without interference from the seal-forming structure 3100.

[0127] An example of a nasal cradle cushion (e.g., an exemplary seal-forming structure disclosed herein) may include an upper saddle or concave region with a positive curvature across the cushion. Also, a nasal cradle cushion may be understood as having a single target seal-forming region or surface, while a pillow cushion may have two target seal-forming regions, one for each nostril. The cradle cushion may also have a rear wall that contacts the patient's upper lip and an upper central surface that contacts the underside of the patient's nose. These two surfaces on the patient's face form a nasolabial angle between them (see FIG. 2E). The cradle cushion may be shaped to have a nasolabial angle in the range of 90 degrees to 120 degrees.

[0128] Additionally, the exemplary seal-forming structure 3100 may be shaped and dimensioned such that, during use, no portion of the seal-forming structure 3100 enters the patient's nares.

[0129] The exemplary seal-forming structure 3100 may include at least two regions of different thicknesses (i.e., lateral support regions 3108 and intermediate region 3114), each of which may vary in various embodiments described further below. In a further example, a third region (in addition to the lateral support regions 3108 and intermediate region 3114) may be provided with a positive lateral region 3110 of another different thickness. In a further example, a fourth region (in addition to the lateral support regions 3108, the positive lateral region 3110 and intermediate region 3114) may be provided with a front region 3109 of another different thickness. As can be seen from the figures, different thicknesses can be created by extending regions of different thicknesses and distances into the interior of the seal-forming structure 3100, leaving the exterior surface of the seal-forming structure 3100 smooth. This exterior surface may not be irregular in the transition regions between the regions of different thickness. Thus, the exterior of the exemplary seal-forming structure 3100 is continuous and smooth.

[0130] 5.3.1.7.1 Lateral support area At each lateral-most side of each seal-forming structure 3100, a lateral support region 3108 may be provided. An exemplary seal-forming structure 3100 may include two lateral support regions 3108, each spaced distally from a plane that bisects the seal-forming structure 3100 parallel to a sagittal plane of the patient in use. The lateral support regions 3108 may be the thickest portions of the seal-forming structure 3100, providing resistance to a pillow being pressed laterally against the seal-forming structure, for example, due to lateral displacement caused by the patient lying down, and providing robust engagement with the patient's wings. The lateral support regions 3108 may be approximately 0.9 mm to approximately 1.5 mm, or approximately 1.3 mm to approximately 1.4 mm, or approximately 1.3 mm, or approximately 1 mm to approximately 1.5 mm thick. The lateral support regions 3108 are the thickest regions of the seal-forming structure 3100 in the depicted figures, and because the exemplary seal-forming structure 3100 is constructed or molded from a single homogenous piece of material (e.g., liquid silicone rubber), the lateral support regions 3108 may also provide the greatest resistance to deformation.

[0131] Additionally, the lateral support regions 3108 may provide sufficient stiffness to ensure proper sealing in the alar nadir region of the patient's face (i.e., the region where the alar terminates at the upper lip adjacent the nasolabial fold), a region of particularly complex geometry. The alar nadir region of the patient's face has particularly complex geometry because at least three facial surfaces (ala, upper lip, and cheek) converge in this region. As such, sufficient stiffness in the lateral support regions 3108 may allow the pulling force from the positioning and stabilizing structure 3300 to urge the seal-forming structure 3100 into the alar nadir region (without buckling). Insufficient stiffness in the portion of the seal-forming structure 3100 that would engage this region of the patient's face, for example due to the material being too thin, may cause wrinkling that may create a leak path from within the sealed region that allows pressurized gas to leak to the atmosphere along the path formed in the wrinkle between the exterior of the seal-forming structure 3100 and the skin of the patient's face.

[0132] The lateral support region 3108 may be positioned below and laterally outward of the patient's face and nose in the area below the patient's ala (e.g., between the nasolabial fold and the area of ​​the upper lip located below the ala).

[0133] To avoid buckling of the sealing surface, a double wall design may be used, as disclosed in Figures 7A-7M of International Application Publication No. WO2017 / 185140A1, the entirety of which is incorporated herein by reference. In examples of the present technology, a seal-forming structure 3100 including a single wall is used, and buckling of the sealing engagement is avoided by, for example, increasing the thickness of the seal-forming structure 3100 in the lateral support regions 3108.

[0134] Additionally, the lateral support regions 3108 may provide resistance to lateral displacement of the seal-forming structure 3100 as the patient's head moves. The seal-forming structure 3100 may be shaped and dimensioned to extend the lateral support regions 3108 around and in contact with the patient's ala when fitting an appropriately sized example to a given patient. Although the ala may be more prone to deformation due to the less stiff facial structures below the skin of the ala (e.g., cartilage and fibro-adipose tissue as shown in FIG. 2H), by providing sufficient stiffness by the lateral support regions 3108, the seal-forming structure 3100 may be able to reliably maintain a sealing engagement with the patient's ala as the patient's head moves (e.g., when one side of the patient interface 3000 is pressed against a pillow by tilting the head).

[0135] Depending on the shape and size of the patient's facial structure (e.g., nose, alar, upper lip and cheeks), the lateral support regions 3108 may contact the patient's alar, upper lip and / or cheeks in use. In some examples, the lateral support regions 3108 may be shaped and dimensioned to avoid the patient's nasal tip and / or subnasal point.

[0136] 67-70 show an example of a seal-forming structure 3100 with an exemplary nostril contour 1001 and nose base contour 1002. While these figures do not show the wing regions of the nose base contour 1002 extending wide enough to contact the lateral support regions 3108, it should be understood that in use the lateral support regions 3108 may extend upward to enclose the wing. Thus, after the nose is received in the seal-forming structure 3100, the lower portion of the patient's wing may not contact the lateral support regions 3108, but the lateral portions of the patient's wing may contact the lateral support regions 3108. This fit is influenced by the size and shape of a given patient's nose, and in some embodiments the patient's nose may be wide enough so that the lower portion of the wing does not contact the lateral support regions 3108 (in addition to the lateral portions of the wing). In a further example, if the patient has a narrow nose, no portion of the wing will come into contact with the lateral support regions 3108.

[0137] As can be seen in Figures 67-70, a relatively abrupt transition (e.g., a steep taper or near step) can be provided between the regions of different thicknesses. Because facial geometry can vary greatly from patient to patient, the abrupt transition can be located almost directly from the underside to the ala on the upper lip.

[0138] The edges of the lateral support regions 3108 may extend based on the curvature of the nose in an upward, outward and inward order from under the patient's alae (e.g., "up" the patient's face on either side of the nose based on the curvature along either side of the nose). Thus, the lateral support regions 3108 support the seal-forming structure 3100 against the patient's face below and to the side of the patient's nose while allowing the intermediate region 3114 to conform and seal to the alae and underside of the patient's nose.

[0139] The lateral support regions 3108 may extend from the plenum chamber 3200 all the way to the corners of the seal-forming structure 3100 to support and stiffen the cushion. In some examples, the lateral support regions 3108 may be thickest near where the seal-forming structure 3100 is joined to the plenum chamber 3200 and then decrease in thickness away from the plenum chamber 3200. However, the lateral support regions 3108 may not extend around the entire periphery of the plenum chamber 3200. For example, the intermediate region 3114, as described below, may extend to the periphery of the plenum chamber 3200 in the central upper / front region of the seal-forming structure 3100.

[0140] While increased thickness in the lateral support regions 3108 is desirable for structural rigidity, the seal-forming structure 3100 may retain some flexibility, allowing the lateral portions of the seal-forming structure 3100 to be pushed laterally or pulled medially (to accommodate different widths). For example, the non-patient facing sides of the seal-forming structure 3100 (particularly the areas on either side of the seal-forming structure 3100 that do not contact the patient) may be thick enough and thin enough to provide the seal-forming structure 3100 with a compressive force in a direction from the patient's nose onto the medial region 3114 when the seal-forming structure 3100 is worn by a patient with a narrow, long nose, such that the lateral sides of the seal-forming structure 3100 (i.e., the lateral support regions 3108) may be pulled medially to bring the seal-forming structure 3100 on either side of the patient's nose into contact with the patient's nose (e.g., at the wings). When a patient with a wider nose wears the seal-forming structure 3100, the seal-forming structure 3100 may be flexible enough so that it does not exert excessive force on the lateral sides of the patient's nose in the medial direction, which may occur if the seal-forming structure 3100 is too stiff to withstand the wider nose.

[0141] 5.3.1.7.2 Intermediate area The intermediate region 3114 may be located centrally in the seal-forming structure 3100. The intermediate region 3114 may be bisected by a plane that is parallel to a sagittal plane of a patient in use. Because the intermediate region 3114 is centrally located, there is only one such region.

[0142] In the illustrated example, nostril openings 3102 may be formed through the intermediate region 3102. The nostril openings 3102 are positioned to be generally aligned with the patient's corresponding nostrils so that pressurized gas flow is provided to the patient's nostrils for inhalation and exhalation is returned to the seal-forming structure 3100 (for release to atmosphere via the plenum chamber vent 3400), as described further below. FIGS. 67-70 show examples of general alignment between the nostril contours 1001 and the corresponding nostril openings 3102. These examples illustrate that the size and shape of the patient's nares vary widely, and therefore the nostril contours 1001 may not necessarily match the size and shape of the nostril openings 1002.

[0143] As can be seen from the examples of Figures 67-70, the intermediate region 3114 may contact a substantial area at the base or underside of the patient's nose. For many patients, this area is a particularly sensitive area. There is also a large variation in the geometry of the base or underside of the patient's nose. Therefore, making the intermediate region 3114 relatively thin compared to other areas of the seal-forming structure 3100 may allow for increased flexibility and conformance to the contours of the patient's face and nose geometry. In the examples shown, the intermediate region 3114 is the thinnest region. In these examples, the thickness of the intermediate region 3114 may be approximately 0.25 mm.

[0144] In the illustrated example, the positive lateral region 3110 is shown laterally outward of the intermediate region 3114, and the lateral support region 3108 is shown further laterally outward. Thus, in some examples, if the nose is wide enough, depending on the size and shape of the patient's nose, the ala may not contact the intermediate region 3114 at all. For patients with narrower noses, a portion of the patient's ala may contact the intermediate region 3114.

[0145] By extending the intermediate region 3114 around the front periphery of the seal-forming structure 3100, the patient's nasal tip may be in contact with an upper portion of the intermediate region 3114. The patient's upper lip and / or subnasal point may be in contact with a lower portion of the intermediate region 3114. The nasal tip, upper lip and subnasal point may also be particularly sensitive areas, and therefore it may be advantageous to increase the compliance of the intermediate region 3114 to engage these sensitive areas to reduce discomfort. As can be seen from these example figures,

[0146] Depending on the shape and size of the patient's facial structures (e.g., nose, alar, upper lip, and cheeks), the intermediate region 3114 may contact the patient's upper lip, subnasal point, and / or nasal tip point in use. In some examples, the intermediate region 3114 may be shaped and dimensioned to avoid the patient's nasal tip point and / or subnasal point.

[0147] Within the intermediate region 3114, there may be a tip region 3117 where the patient's tip may contact the seal-forming structure 3100. However, it should be understood that for a short nose, the tip may not reach the tip region 3117, and for a long nose, the tip may extend beyond the tip region 3117, so that the tip in either case does not contact the tip region 3117. The tip region 3117 in the examples of Figures 16-28 and 67 and 29-36 and 68 may extend forward (e.g., away from the patient) of the seal-forming structure, so that a portion of the tip region 3117 does not contact the patient's face. With such an arrangement, engagement of the tip may also pull the lateral side of the seal-forming structure 3100 in a medial direction to allow for wing engagement. The nose tip regions 3117 in the examples of Figures 37-44 and 69 and 45-52 and 70 cannot extend too distally to have portions that cannot contact the patient's nose because their shape is for a wider nose that can necessarily properly engage the lateral portions of the seal-forming structure 3100.

[0148] Within the intermediate region 3114, an upper lip region 3116 may be provided where the patient's upper lip may contact the seal-forming structure 3100. The patient's sub-nose point may be in contact with the seal-forming structure 3100 at the upper lip region 3116. In some examples, the upper lip region 3116 may be adjacent to, but not in direct contact with, the patient's sub-nose point, such that a gap may be obtained between the patient's face and the seal-forming structure 3100 within the boundaries of the seal formed against the patient's face.

[0149] Additionally, the intermediate region 3114 is relatively thin and may allow for expansion of the seal-forming structure 3100 during use due to the pressure of air within the seal-forming structure 3100. Inflation of the seal-forming structure 3100 during use may facilitate biasing the intermediate region 3114 against the contours of the patient's face and nose (e.g., on the underside, at the alar, at the upper lip, at the subnasal point, and / or at the nasal tip) to ensure a proper seal.

[0150] While a relatively thin material thickness may provide the benefits described above and below for the intermediate region 3114, making the intermediate region 3114 too thin may result in excessive wrinkling, which may create a gas leakage path and allow gas to escape beyond the sealing boundary to the atmosphere. A sufficiently thick intermediate region 3114 may also be advantageous in maintaining a stable seal that is not easily displaced by patient movement or contact with objects such as pillows. Wrinkling may be of particular concern in the nasal tip region 3117, particularly along the centerline of the seal-forming structure 3100 (i.e., along a plane parallel to the sagittal plane of the patient in use). As such, in some instances, the intermediate region 3114 may be thicker in the nasal tip region 3117 compared to other portions of the intermediate region 3114.

[0151] A bridge portion 3104 may be provided between the nostril openings 3102 in the intermediate region 3114. The bridge portion 3104 may be long enough to be relaxed in an undeformed state, allowing the bridge portion 3104 to accommodate (without stretching) deformation of the seal-forming structure 3100 when the patient's nose contacts the intermediate region 3114. The bridge portion 3104 may be thicker than the intermediate region 3114, or may be the same thickness. In an example, the bridge portion has a thickness of approximately 0.35 mm. Another way to resist tearing is to make the bridge portion 3104 wider. Constructing the bridge portion 3104 with a relatively greater thickness than the adjacent intermediate region 3114 may help avoid tearing when the bridge portion 3104 stretches due to engagement of the seal-forming structure 3100 with the patient's nose. The S-shape of the bridge portion 3104 may allow it to be straight and therefore resist movement of the top of the mid-region 3114 away from the underside of the upper lip. The bridge portion 3104 may be arched, curved, and / or slightly folded in its undeformed state.

[0152] The bridge portion 3104 may be longer or may have an amount of material beyond that required to fill the gap between the top and bottom of the intermediate region 3114. The use of such excess material allows the bridge portion 3104 to stretch from straight to taut. Without the excess material, when force is applied to the top of the intermediate region 3114, the bridge portion 3104 becomes taut and the bridge portion 3104 cannot tolerate even slight movement of the top of the intermediate region 3114 (thus, the effect of accommodating a longer nose may not be achieved). Because the bridge portion 3104 does not necessarily engage and seal against the bridge of the nose, it may be possible for the bridge portion 3104 to remain relaxed while completely sealing around the patient's nose and still provide an adequate seal for small noses.

[0153] The bridge portion 3104 may maintain the integrity of the seal-forming structure 3100 in the intermediate region 3114. If the bridge portion 3104 were not provided, but instead a single air opening were provided, the wall thickness of the intermediate region 3114 would be relatively thin, and there would be a risk that the tip region 3117 of the seal-forming structure 3100 would rupture (i.e., the pressure from the gas would cause the sealing surface to rupture away from the nose, disrupting the sealing engagement) if the seal-forming structure 3100 were to be refitted (e.g., by pulling and repositioning the face) or subjected to strong dynamic loading under pressure. By providing the bridge portion 3104, the tip region 3117 would be restrained to the upper lip region 3116, thus avoiding rupture.

[0154] Additionally, the bridge portion 3104 may avoid set-up errors by the user by preventing the patient's nose from being inserted into what would otherwise be a single orifice.

[0155] 5.3.1.7.3 Positive lateral area The positive lateral regions 3110 may be disposed laterally inward or medially relative to the lateral support regions 3108. The positive lateral regions 3110 may be disposed laterally outward relative to the intermediate region 3114. The exemplary seal-forming structure 3100 may include two positive lateral regions 3110. Each of the two positive lateral regions 3110 is spaced distally from a plane that bisects the seal-forming structure 3100 parallel to a sagittal plane of the patient in use. The positive lateral regions 3110 may be disposed such that each positive lateral region 3110 is adjacent to a corresponding lateral support region 3108 on one side and adjacent to a corresponding side of the intermediate region 3114 on the other side.

[0156] Depending on the shape and size of the patient's facial structure (e.g., nose, alar, upper lip, and cheeks), the positive lateral region 3110 may contact the patient's alar in use. In some examples, the positive lateral region 3110 may be shaped and sized to avoid the patient's upper lip, cheek, nasal tip, and / or subnasal point. FIGS. 67-70 show examples of how the nose base contour 1002 extends into the positive lateral region 3110 at its widest point (which is the lateral boundary of the base of the alar) and the alar contacts the positive lateral region 3110. In other examples, if the patient has a relatively narrow nose, the nose base contour 1002 may remain within the boundary of the middle region 3114, so that the positive lateral region 3110 and the lateral support region 3108 contact the lateral portions of the alar but not the underside. In other examples, if the patient has a relatively wide nose, the base of the wing may extend beyond the positive lateral region 3110 into the lateral support region 3108.

[0157] In some examples, the positive lateral region 3110 may be thicker than the intermediate region 3110 and thinner than the lateral support region 3108. The thickness of the positive lateral region 3110 may be from about 0.5 mm to about 0.7 mm or about 0.6 mm or about 0.75 mm.

[0158] 5.3.1.7.4 Forward area In a further example of the seal-forming structure 3100, a front region 3109 may be provided. The front region 3109 may face away from the patient in use, and in some examples, the patient's face may not contact the front region 3109. In some examples, the front region 3109 may be thinner than the lateral support regions 3108 and thicker than the middle region 3114. In some examples, the thickness of the front region 3109 may be about 0.5 mm to about 0.7 mm, or about 0.6 mm, or about 0.75 mm.

[0159] The front region 3109 may support the seal-forming structure 3100 by resisting compression of the seal-forming structure 3100 in a front direction during use.

[0160] 5.3.1.7.5 Corner area The example seal-forming structure 3100 may also include two corner regions 3115 formed near the area where the intermediate region 3114, the lateral support region 3108, and the positive lateral region 3110 converge. The corner regions 3115 may be located medially relative to the lateral support region 3108 or relative to the lateral support region 3108 and the positive lateral region 3110.

[0161] As can be seen in FIGS. 67-70, the corner region 3115 may engage the patient's nose and meet at the area where the nose bottom contour 1002 terminates (i.e., at the alar nadir region). The corner region 3115 may be shaped and sized to extend into and seal the alar nadir region of the patient's face. As noted above, making the lateral support region 3108 relatively thick may be beneficial to ensure that a proper seal is maintained in areas of relatively complex facial geometry (e.g., the alar nadir region). Thus, extending the corner region 3115 medially into the lateral support region 3108 or the lateral support region 3108 and the positive lateral region 3110 into the alar nadir region provides an effective seal against the complex concave geometry of this region.

[0162] The nasal alar may be significantly curvilinear, and for many patients, the alar may join the face in a large recessed pocket or depression. These pockets may result from the alar curvilinearly extending medially to the sagittal plane between the widest parts of the nose (i.e., along a line drawn from alar crest to alar crest across the sagittal plane) and the junction of the face and alar (i.e., the alar nadir region). Providing a thin material (i.e., components of the mid-region 3114 of the corner region 3115) to engage these corners of the patient's facial geometry may allow the seal-forming structure 3100 to deform to match the curvature of the alar and fill (at least partially, if not completely) any depressions that may exist at the lower corners of the patient's nose. The seal-forming structure 3100 may be configured such that edges of the lateral support regions 3108 are positioned laterally outwardly of the wings on the patient's face and sufficiently proximate to the wings such that areas of the cushion on either underside of the nose that contact the patient's face are provided in the lateral support regions 3108 to support and stabilize the seal-forming structure 3100. The components of the corner regions 3115 intermediate regions 3114 may be deformable to the extent that a ledge is formed on which the patient's wings (at least a portion proximate the upper lip) may rest in use, thereby enabling the seal-forming structure 3100 to conform around the underside of the patient's nose (particularly adjacent the upper lip) in use.

[0163] 5.3.1.7.6 Wrinkle resistance By providing an intermediate region 3114 in the seal-forming structure 3100 so as to seal against the underside of the patient's nose, and providing the positive lateral regions 3110 and / or the lateral support portions 3108 around part or all of the intermediate region 3114 generally around the patient's nose, propagation of wrinkles formed on the relatively flexible and thin-walled intermediate region 3114 may be avoided.

[0164] The middle region 3114 may be relatively flexible due to its thin wall thickness, and wrinkles are more likely to occur in the middle region 3114. The front side region 3110 may be thicker than the middle region 3114, and therefore less likely to wrinkle (in the wing region, where wrinkles are more likely to occur due to complex geometry). If wrinkles start at the surface of the seal-forming structure 3100 that seals with the patient's skin and continue outside the seal boundary, the wrinkles may create a leak path through which gas may leak through the wrinkles to the atmosphere and pass through the patient's face. In such cases, noise may be generated due to gushing and / or confusion caused by the perception of gas flowing along the skin.

[0165] The positive lateral regions 3110, due to their greater wall thickness, may be able to resist wrinkling. If wrinkling does occur in the intermediate region 3114, the positive lateral regions 3110 may be able to limit the size of the wrinkling so that it does not continue to the sides of the seal-forming structure 3100 and through the skin-sealing surface. Thus, the positive lateral regions 3110 are positioned at or near the edge of the patient's alar around the base of the nose to act as a barrier against folding that closely follows the shape of the patient's nose.

[0166] Additionally, the positive lateral regions 3110 may provide a constant intermediate preload to the lateral sides of the seal-forming structure 3100. The patient's nose may act against this preload when the patient is wearing the mask, forcing the lateral sides of the seal-forming structure 3100 into the wings to create a stable and robust seal. The preload may be designed so that it is large enough to allow the seal-forming structure 3100 to fit narrow noses and create a robust seal, yet small enough to not cause discomfort or resistance in sealing wider noses. Additionally, adding preload to the sides of the nose may provide a suspension between the nose and the remainder of the seal-forming structure 3100, providing a decoupling effect and allowing some lateral movement of the cushion in use without disrupting the seal.

[0167] 5.3.1.7.7 Seal-forming structure sealing and comfort of the technology for the patient In an external clinical study, 19 / 23 patients rated the technology's seal-forming structure 3100 as being above a comfort score of 7 on a scale of 1-10 (10 being the highest). In an external clinical study, 15 / 23 patients rated the technology's seal-forming structure 3100 as being above a comfort score of 9 or 10.

[0168] In a fit survey, the majority of patients (30 / 33) rated the initial fit of the seal-forming structure 3100 of the present technology as more favorable than the competitor's product (Respironics DreamWear) and praised the fit, adjustment, and seal. Thirty of 33 patients (90%) found the seal-forming structure 3100 of the present technology to be extremely easy to fit and adjust.

[0169] Thirty-one of the 36 patients rated the seal of the seal-forming structure 3100 of the present invention as a 9 or 10 on a scale of 1 to 10, with 10 being the best. In this technician observation study, patients rated the seal of the seal-forming structure 3100 of the present invention as more resistant to in-bed movement than a competitor's product (Respironics DreamWear).

[0170] The majority of patients (31 of 36 patients) who tried the present technology's seal-forming structure 3100 liked it so much that they would rather take it home as their own mask than the competitor's product (Respironics DreamWear).

[0171] The comfort preference mentioned in the above paragraph may relate to the comfort imparted to the patient from the intermediate region 3114, which provides a compliant and conforming engagement with sensitive areas of the patient's face. The overall shape of the exemplary seal-forming structure 3100 may also contribute to comfort.

[0172] The sealing preferences mentioned in the above paragraph may relate to the ability of the middle region 3114 to conform to the patient's nose and form a proper seal. The front lateral regions 3110, the lateral support regions 3108 and the corner regions 3115 may also contribute to the sealing preferences of the seal-forming structure 3100 of the present technology due to the manner in which they can engage complex facial geometry and maintain an effective seal.

[0173] 5.3.2 Plenum chamber The plenum chamber 3200 has a perimeter with a shape that is complementary to the surface contour of an average human face in the area where a seal is formed in use. In use, the peripheral edge of the plenum chamber 3200 is positioned proximate to the adjacent surface of the face. Actual contact with the face is provided by the seal-forming structure 3100. The seal-forming structure 3100 may extend around the entire edge of the plenum chamber 3200 in use. In some forms, the plenum chamber 3200 and the seal-forming structure 3100 are formed from a single homogenous piece of material.

[0174] In some forms of the present technology, the plenum chamber 3200 does not cover the patient's eye when in use. In other words, the eye is outside the pressurized space defined by the plenum chamber. Such forms may improve treatment compliance because they are often less intrusive and / or more comfortable for the wearer.

[0175] In certain forms of the present technology, the plenum chamber 3200 is constructed from a transparent material (e.g., clear polycarbonate). The use of a transparent material may reduce the intrusiveness of the patient interface and aid in improved compliance with treatment. The use of a transparent material may aid the clinician in seeing the placement and function of the patient interface.

[0176] In certain forms of the present technology, the plenum chamber 3200 is constructed from a translucent material. The use of a translucent material can make the patient interface less intrusive and can help improve compliance with treatment.

[0177] 22-28, 35, 36, 43, 44, 51 and 52 show examples of a seal-forming structure 3100 with a plenum chamber 3200. The seal-forming structure 3100 may be formed from a single homogenous piece of material (e.g., liquid silicone rubber) as described above and may include a plenum chamber connection opening 3106 where the seal-forming structure 3100 is bonded to the plenum chamber 3200. The connection between the seal-forming structure 3100 and the plenum chamber 3200 at the plenum chamber connection opening 3106 may be a permanent connection. The connection between the seal-forming structure 3100 and the plenum chamber 3200 at the plenum chamber connection opening 3106 may be a chemical bond. The bond between the seal-forming structure 3100 and the plenum chamber 3200 at the plenum chamber connection opening 3106 may be made without a mechanical interlock.

[0178] On each side of the plenum chamber 3200, a plenum chamber end 3202 may be provided as a hollow passage. A plenum chamber connector 3204 may also be provided on each side of the plenum chamber 3200 outwardly of the plenum chamber end 3202. The plenum chamber connector 3204 may connect to each end 3314 of the positioning and stabilizing structure 3300. The connection between the plenum chamber connector 3204 and each end 3314 of the positioning and stabilizing structure 3300 may be removable on both sides. In other examples, a permanent connection may be provided on one side and a releasable connection on the other side. In further examples, the connection between the plenum chamber connector 3204 and each end 3314 of the positioning and stabilizing structure 3300 may be permanent on both sides.

[0179] The plenum chamber end 3202 may receive a flow of pressurized gas from the positioning and stabilizing structure 3300. The flow of pressurized gas may then pass through the plenum chamber 3200 and then through the seal-forming structure 3100 and into the patient's airway for exhalation.

[0180] 55-61 show how the end 3114 of the positioning and stabilizing structure 3300 may be connected to the plenum chamber end 3202. In these examples, each plenum chamber connector 3204 may include a notch 3206. The notch 3206 connects to a clip protrusion 3322 of the clip 3320 with a snap fit. Each plenum chamber connector 3204 may be splittable, allowing for deformation within the clip 3320 upon connection. Each clip 3320 may be bonded to a clip overmold 3318. The clip overmold 3318 is an intermediate component between the ends 3314 of the positioning and stabilizing structure 3300. Surrounding the end 3314 of the positioning and stabilizing structure 3300 may be a lip 3324 that seals the plenum chamber connector 3204. The lip 3324 may surround the entire opening at the end 3314 of the positioning and stabilizing structure 3300, ensuring a complete airtight seal against the plenum chamber connector end 3204, such that the entire flow of pressurized gas passing through the positioning and stabilizing structure 3330, through the plenum chamber 3200 and the seal forming structure 3100, reaches the patient.

[0181] The plenum chamber connectors 3204 may each include a chamfered edge 3208 and a slot 3209. The chamfered edge 3208 may provide a surface that engages with a clip protrusion 3322 of the clip 3320, as shown for example in FIG. 57. The slot 3209 may allow the plenum chamber connectors 3204 to deform and reduce in cross section upon insertion into the corresponding clip 3320.

[0182] The clip overmold 3318 can be a thin silicone material between the clip 3320 (e.g., constructed of polycarbonate) and the positioning and stabilizing structure 3300. The clip overmold 3318 can be constructed of silicone to improve the bond between the positioning and stabilizing structure 3300 and the clip 3320. The bond between compression grade silicone (e.g., used in the positioning and stabilizing structure 3300) and plastic (e.g., polycarbonate for the clip 332) can be weak. Therefore, overmolding a layer of LSR (liquid silicone rubber) in the form of the clip overmold 3318 between the clip 3320 and the compression grade silicone positioning and stabilizing structure 3300 can improve the bond.

[0183] 56 also shows an alignment feature, with two arrows, one on the plenum chamber 3200 and one on the positioning and stabilizing structure 3300, to indicate proper engagement of the plenum chamber 3200 and the positioning and stabilizing structure 3300.

[0184] Chamfering the ends of the plenum chamber connector 3204 provides a lead-in angle for connection to the positioning and stabilizing structure 3300. These lead-in features may allow for a reduction in the force required to insert the plenum chamber connector 3204 into the ends 3314 (particularly the clip 3320) of the positioning and stabilizing structure 3300. Additionally, providing lead-in chamfers on the plenum chamber connector 3204 may aid in self-alignment with the clip 3320. The clip 3320 may also provide lead-in chamfers, which may further aid in deformation of the plenum chamber connector 3204 for connection.

[0185] The notches 3206 may be provided in the plenum chamber connector 3204 to receive the clips 3320 for a snap-fit ​​connection during assembly. After the clips 3320 snap into the corresponding notches 3206, the plenum chamber 3200 and the positioning and stabilizing structure 3300 are removably joined together. Disconnection of these components may be achieved by applying sufficient force to cause the clip protrusions 3322 to escape the corresponding notches 3206. The edges of each of the notches 3206 distal to the end of the plenum chamber connector 3204 are provided with an angled surface relative to the direction in which the plenum chamber 3200 is pulled from the clips 3320 when disassembling the plenum chamber 3200 from the positioning and stabilizing structure 3300. This retention angle may provide an optimal force to retain the positioning and stabilizing structure 3300 during use while facilitating disconnection of the plenum chamber 3200 and the positioning and stabilizing structure 3300. The steeper the angle, the more secure the connection and the less likely unintentional disassembly, but the more difficult it is for the patient to disassemble the system. The retention angles described strike a balance that provides secure assembly and ease of disassembly.

[0186] The plenum chamber connectors 3204 may be curved to fit the curve of the interior contour of the positioning and stabilizing structure 3300. The top one of the plenum chamber connectors 3204 in FIG. 57 is curved and does not flex when connecting and disconnecting. The bottom one of the plenum chamber connectors 3204 in FIG. 57 is not curved and does not flex when connecting and disconnecting, allowing the plenum chamber connector 3204 to snap into the inner clip 3320 of the positioning and stabilizing structure 3300.

[0187] Providing a sufficient radius of curvature to the base of the branch between the plenum chamber connectors 3204 can avoid stress concentrations that would otherwise cause the rigid material (e.g., polycarbonate) to fail at this location due to stresses generated when the lower one of the plenum chamber connectors 3204 flexes to receive the clip 3320.

[0188] The cross-sectional shape of the plenum chamber connector 3204 may not exactly follow the cross-sectional shape of the clip 3320. There may be more clearance at the sides of the plenum chamber connector 3204 than at the top and bottom, which may allow the clip 3320 to flex (without interfering with the plenum chamber connector 3204) during assembly and disassembly. When the plenum chamber connector 3204 is pulled from the clip 3320, a force may be applied from the plenum chamber connector 3204 to the clip 3320 in the upward and downward directions of FIG. 57, which may result in the sides of the clip 3320 being pulled inward as the clip deforms. By providing a clearance between the sides of the clip 3320 and the plenum chamber connector 3204, there may be some space for the sides of the clip 3320 to move inward (without interfering with the plenum chamber connector 3204). The thickness of the clip 3320 may be selected to provide both the flexibility and retention necessary to maintain a secure connection.

[0189] The end 3314 of the positioning and stabilizing structure 3300 is small enough to form an interference fit with the plenum chamber connector 3204 to provide a seal between the plenum chamber 3200 and the positioning and stabilizing structure 3300. The tapered cross section of the lip 3324 may prevent the lip 3324 from rotating during assembly (which may adversely affect the seal).

[0190] 60 and 61, the interior opening 3201 between the plenum chamber connector 3204 and the interior of the plenum chamber 3200 is very similar in geometry to the positioning and stabilizing structure 3300, thus avoiding changes that may adversely affect flow dynamics and cause excessive pressure drop. The transition geometry from the inside of the plenum chamber connector 3204 to the interior of the plenum chamber 3200 and seal-forming structure 3100 may also minimize pressure drop and impedance.

[0191] 5.3.2.1 Alternative plenum chamber designs 64-66 show variations of the plenum chamber 3200. In one embodiment, the plenum chamber 3200 may be formed of a flexible material such as silicone (rather than a rigid material such as polycarbonate). As such, the plenum chamber 3200 may be more flexible and better able to withstand or resolve lateral forces on the positioning and stabilizing structure 3300, allowing for reduced forces on the seal-forming structure 3100 that may cause seal failure. A plenum chamber 3200 made from a more flexible material (e.g., silicone) may also be easier to remove from tooling during manufacturing. In such an embodiment, the connections to the gas-carrying positioning and stabilizing structure 3300 may also be formed from a rigid material such as polycarbonate.

[0192] In such an embodiment, the seal-forming structure 3100 may be constructed of a very flexible silicone (e.g., in the range of 30-40 durometer). The plenum chamber 3200 may be less flexible (although more flexible than a rigid material such as polycarbonate), with a hardness in the range of, for example, 70-90 durometer. The plenum chamber connector 3204 may be formed of a hard plastic material (e.g., polycarbonate or nylon). The vent hole 3400 may be provided as a vent hole in a flexible material (e.g., the silicone of the plenum chamber 3200) if the hole is large enough (or the silicone is rigid enough). The hole in such an embodiment needs to be large enough or the material needs to be sufficient to avoid blockage. Alternatively, the plenum chamber 3200 may have a larger opening into which an insert (e.g., a rigid material such as polycarbonate) with a vent hole can be fitted or overmolded. This alternative is shown in Figures 62-63. A diffuser may be placed on or added to the ventilation insert 3242 .

[0193] In the example shown in Figures 64-66, the plenum chamber 3200 is divided into two plenum chamber portions 3260 separated by a flexible material such as silicone. As such, the plenum chamber 3200 may flex in the middle. This may allow for some decoupling of forces between the positioning and stabilizing structure 3300 and the seal-forming structure 3100, and may also allow the seal-forming structure 3100 to deform around and surround the patient's face. Each of the plenum chamber portions 3260 may be connected to the positioning and stabilizing structure 3300 to direct gas into the plenum chamber 3200. The plenum chamber portion 3260 may also include a vent 3400.

[0194] 5.3.3 Positioning and stabilizing structures The seal-forming structure 3100 of the patient interface 3000 of the present technology may be held in a sealed position by the positioning and stabilising structure 3300 in use.

[0195] In one form, the positioning and stabilizing structure 3300 provides at least enough retention force to overcome the effect of the positive pressure in the plenum chamber 3200 to lift off the face.

[0196] In one form, the positioning and stabilising structure 3300 provides a retaining force sufficient to overcome the attractive force on the patient interface 3000.

[0197] In one form, the positioning and stabilizing structure 3300 provides a retention force as a safety margin to eliminate the possibility of destructive action on the patient interface 3000 (e.g., due to tube drag or inadvertent interference with the patient interface).

[0198] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured to be worn by a patient while sleeping. In one embodiment, the positioning and stabilizing structure 3300 has a low profile or cross-sectional thickness to reduce the perceived or actual bulk of the device. In one embodiment, the positioning and stabilizing structure 3300 includes at least one strap having a rectangular cross-section. In one embodiment, the positioning and stabilizing structure 3300 includes at least one flat strap.

[0199] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured so as not to be excessively large or bulky in size that would interfere with a patient sleeping in a supine sleep position with the posterior region of the patient's head resting on a pillow.

[0200] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured so as not to be excessively large or bulky in size that would interfere with a patient sleeping in a lateral sleep position with the side region of the patient's head resting on a pillow.

[0201] In one form of the present technology, the positioning and stabilizing structure 3300 includes a decoupling section disposed between an anterior section of the positioning and stabilizing structure 3300 and a posterior section of the positioning and stabilizing structure 3300. The decoupling section does not resist compression and can be, for example, a flexible or flimsy strap. The decoupling section is constructed and positioned such that when a patient lies down with their head on a pillow, the presence of the decoupling section prevents forces from being transferred along the positioning and stabilizing structure 3300 to the posterior section, disrupting the seal.

[0202] In one form of the present technology, the positioning and stabilizing structure 3300 includes a strap constructed from a laminate of a fabric patient-contacting layer, a foam material inner layer, and a fabric outer layer. In one form, the foam material is porous to allow moisture (e.g., sweat) to pass through the strap. In one form, the fabric outer layer includes a loop material that engages with a hook material portion.

[0203] In certain forms of the present technology, the positioning and stabilizing structure 3300 includes a stretchable (e.g., stretchable with elasticity) strap. For example, the strap can be configured to be tensioned in use to direct a force that urges the seal-forming structure into contact with a portion of the patient's face. In one example, the strap can be configured as a tie.

[0204] In one form of the present technology, the positioning and stabilizing structure includes a first tie constructed and arranged such that, in use, at least a portion of its lower edge passes over and moves to a superior-temporal point on the patient's head to cover a portion of the parietal bone without covering the occipital bone.

[0205] In one form of the present technology, suitable for a nasal only or full face mask, the positioning and stabilizing structure includes a second tie constructed and arranged such that, in use, at least a portion of its upper edge passes under the lower ear base point on the underside of the patient's head and covers or rests under the occipital bone of the patient's head.

[0206] In one form of the present technology, suitable for a nasal only or full face mask, the positioning and stabilizing structure includes a third tie constructed and arranged to interconnect the first tie and the second tie in a manner that reduces the tendency of the first tie and the second tie to move apart relative to one another.

[0207] In certain forms of the present technology, the positioning and stabilizing structure 3300 includes straps that are bendable, e.g., non-rigid. An advantage of this embodiment is that the straps are more comfortable when the patient lies down to sleep.

[0208] In a particular form of the present technology, the positioning and stabilizing structure 3300 includes straps configured to be breathable to allow water vapor to pass therethrough.

[0209] In certain forms of the present technology, a system is provided that includes more than one positioning and stabilizing structure 3300. Each positioning and stabilizing structure 3300 is configured to provide a holding force to accommodate a range of different sizes and / or shapes. For example, a system may include one form of positioning and stabilizing structure 3300 that is suitable for a large sized head but not a small sized head and another that is suitable for a small sized head but not a large sized head.

[0210] 5.3.3.1 Positioning and stabilization structures of the technology 7-15 show examples of the present technology including a positioning and stabilizing structure 3300. In these examples, the positioning and stabilizing structure 3300 includes a lateral portion 3302 and an upper portion 3304. The lateral portion 3302 and the upper portion 3304 are in the form of a conduit or tube that directs a flow of pressurized gas from the hub 3306 to the end portion 3314. The positioning and stabilizing structure 3300 may be positioned such that the hub 3306 and decoupling structure 3500 are positioned above the patient's head in use. As described below, the decoupling structure 3500 may be rotatable within the hub 3306 such that when the patient is wearing the patient interface 3000, for example during treatment, the hub 3306 and decoupling structure 3500 are positioned above the patient's head, allowing the patient to move more freely (without becoming entangled with the air circuit 4170).

[0211] The positioning and stabilizing structure 3300 may be constructed from silicone. For example, the sides 3302, top 3304, hub 3306 and side ends 3314 may be constructed or molded from a single piece of silicone.

[0212] The upper portion 3304 of the positioning and stabilizing structure 3300 has peaks and valleys (or bellows) that allow the upper portion 3304 to conform to the shape of a corresponding portion of a patient's head during use. The peaks and valleys of the upper portion 3304 allow the upper portion 3304 to expand or contract along a longitudinal axis to accommodate larger or smaller heads. The peaks and valleys of the upper portion 3304 allow the upper portion 3304 to flex to different radii of curvature to accommodate different shapes and sizes of patient heads.

[0213] The sides 3302 of the positioning and stabilizing structure 3300 do not have to be formed with the peaks and valleys of the top 3304. As such, the sides 3302 may be able to be less extensible and flexible than the top 3304, which may be advantageous as it reduces the shape and size variability of the sides of the patient's head.

[0214] The end 3314 may connect to each plenum chamber end 3202. As described above, the plenum chamber end 3202 receives the pressurized gas flow from the positioning and stabilizing structure 3300. This pressurized gas flow passes through the plenum chamber 3200 and the seal-forming structure 3100 to the patient's airway. As described above, the end 3314 may include a clip overmold 3318 and a clip 3320 to facilitate connection of the end 3314 to the plenum chamber connector 3204 of each plenum chamber end 3202.

[0215] The side portions 3302 may also each include a tab 3308. The tab 3308 receives a rear strap end 3311 of the rear strap 3310. The rear strap 3310 may be length adjustable, for example, by an arrangement of hook and loop material, so that one of the rear strap ends 3311 and the remainder of the rear strap 3310 includes hook material on the outside and the other includes loop material on the outside. Because the rear strap 3310 is length adjustable, tension on the side portions 3302 may be increased to draw the seal-forming structure 3100 into sealing engagement with the patient's face at a desired amount of pressure (i.e., tight enough to avoid leakage but not so tight as to cause discomfort).

[0216] The lateral portion 3302 may also be provided with a sleeve 3312 to cushion the patient's face from the lateral portion 3302. The sleeve 3312 may be constructed of a soft feeling, breathable textile material.

[0217] 5.3.4 Ventilation In one form, the patient interface 3000 includes a vent 3400 constructed and arranged to allow for the expulsion of exhaled gases (eg, carbon dioxide).

[0218] In certain configurations, the vent 3400 is configured to allow continuous vent flow from the interior of the plenum chamber 3200 to atmosphere when pressure in the plenum chamber is positive with respect to atmosphere. The vent 3400 is configured such that the magnitude of the vent flow is sufficient to reduce rebreathing of exhaled CO2 by the patient while maintaining a therapeutic pressure in the plenum chamber in use.

[0219] The ventilation section 3400 in one embodiment according to the present technology includes a plurality of holes (eg, about 20 to about 80 holes, or about 40 to about 60 holes, or about 45 to about 55 holes).

[0220] The vent 3400 may be disposed within the plenum chamber 3200. The plenum chamber vent 3400 may include a plurality of holes as described above. The holes of the plenum chamber vent 3400 may be divided into two laterally spaced groups. The axes of the flow paths through each of the holes of the plenum chamber vent 3400 may be parallel, thus avoiding cross-flow and further noise generation. The vent holes may be circular.

[0221] FIG. 54 also shows how the radius of the holes in the plenum chamber vent 3400 decreases from the inside to the outside of the plenum chamber 3200. As shown, each vent hole has a draft angle. The diameter of each hole is smaller at the leading edge than at the trailing edge. The draft angle means that the cross section of the hole does not decrease across the entire thickness of the chassis, which helps provide carbon dioxide flushing at high humidification levels. Additionally, a large draft angle may make the plenum chamber 3200 easier to manufacture (especially if the plenum chamber 3200 is formed from an injection molded plastic material). The draft angle allows for a relatively thick vent pin to be used in the mold, facilitating injection.

[0222] The holes in the plenum chamber vent 3400 may be provided in two sets towards the middle of the plenum chamber 3200, and the sets may be symmetrical about the centerline of the plenum chamber 3200. Providing multiple vent hole patterns may allow for noise reduction and may allow for dispersion of flow crowding.

[0223] The holes in the plenum chamber vent 3400 may be positioned at an optimal distance away from the centerline of the plenum chamber 3200. Positioning the holes in the plenum chamber vent 3400 toward the centerline is advantageous because it reduces the chance of the holes becoming blocked when the patient is lying down. However, positioning the holes too close to the middle of the plenum chamber 3200 may cause the plenum chamber 3200 to be too weak in the center, especially since the cross section of the plenum chamber 3200 in the illustrated example is smallest in the center (due to the overall shape of the plenum chamber 3200). The location of the holes in the plenum chamber vent 3400 may allow the middle of the chassis to be sufficiently strong while avoiding blocking of the holes when lying down.

[0224] The size of each vent hole and the number of vent holes can be optimized to achieve a balance between noise reduction and achieving the necessary carbon dioxide flushing even when humidification is extreme. In the described example, the vent holes of the plenum chamber vent 3400 can provide the entire ventilation volume of the system. The decoupling structure 3500 can include a decoupling structure vent 3402. The decoupling structure vent 3402 can include one hole or multiple holes through the decoupling structure 3500. The decoupling structure vent 3402 can function to bleed off excess pressure generated by the RPT device 4000 (before it reaches the patient), while the plenum chamber vent 3400 can function to flush out carbon dioxide exhaled by the patient during treatment.

[0225] 62 and 63 show another example of a plenum chamber vent 3400. In this example, holes are provided in the vent insert 3242. The vent insert 3242 is removably or permanently attached to the plenum chamber 3200 at the vent insert opening 3240. The vent insert 3242 may be constructed from a material that is more flexible than the material of the plenum chamber 3200.

[0226] 5.3.5 Decoupling Structures (Singular or Plural) In one form, the patient interface 3000 includes at least one decoupling structure (eg, a swivel or ball socket).

[0227] The hub 3306 as described above is connected to the decoupling structure 3500 which is a rotatable elbow in these examples. The decoupling structure 3500 may be rotatable 360° within the hub 3306 in use. To remove the decoupling structure 3500 from the hub 3306, a button 3504 is manually pressed which releases a catch (not shown) from within the hub 3306.

[0228] The decoupling structure 3500 may also include a swivel 3502 that allows for a rotatable connection to the air circuit 4170.

[0229] The decoupling structure 3500 being rotatable, the decoupling structure 3500 being in the form of an elbow, and the swivel 3502 being rotatable on the decoupling structure 3500 can lead to increased degrees of freedom, resulting in reduced tube drag and torque on the patient interface 3000 due to connection to the air circuit 4170.

[0230] 5.3.6 Connection Ports The connection port 3600 allows connection to the air circuit 4170 .

[0231] 5.3.7 Forehead support In one form, the patient interface 3000 includes a forehead support 3700.

[0232] 5.3.8 Anti-asphyxiation valves In one form, the patient interface 3000 includes an anti-asphyxiation valve.

[0233] 5.3.9 Ports In one form of the present technology, the patient interface 3000 includes one or more ports that allow access to the volume within the plenum chamber 3200. In one form, this allows a clinician to provide supplemental oxygen. In one form, this allows a characteristic of the gas (e.g., pressure) within the plenum chamber 3200 to be directly measured.

[0234] 5.4 RPT Devices An RPT device 4000 according to one aspect of the present technology includes mechanical, pneumatic, and / or electrical components and is configured to execute one or more algorithms 4300 (e.g., any of the methods described herein, in whole or in part). The RPT device 4000 may be configured to generate an airflow that is delivered to a patient's airway for treatment of one or more of the respiratory conditions described anywhere herein, for example.

[0235] In one form, the RPT device 4000 is constructed and arranged to deliver airflow in the range of -20 L / min to +150 L / min while maintaining a positive pressure of at least 6 cmH2O, or at least 10 cmH2O, or at least 20 cmH2O.

[0236] The RPT device may have an outer housing 4010. The outer housing 4010 is formed by two portions, an upper portion 4012 and a lower portion 4014. Additionally, the outer housing 4010 may include one or more panel(s) 4015. The RPT device 4000 includes a chassis 4016 that supports one or more internal components of the RPT device 4000. The RPT device 4000 may include a handle 4018.

[0237] The air pressure path of the pneumatic RPT device 4000 may include one or more air circuit items (e.g., an inlet air filter 4112, an inlet muffler 4122, a pressure generator 4140 (e.g., a blower 4142) capable of supplying air at positive pressure, an outlet muffler 4124) and one or more transducers 4270 (e.g., a pressure sensor 4272 and a flow sensor 4274).

[0238] One or more of the pneumatic path items may be disposed within a removable unitary structure referred to as a pneumatic block 4020. The pneumatic block 4020 may be disposed within the outer housing 4010. In one form, the pneumatic block 4020 is supported by or formed as part of the chassis 4016.

[0239] The RPT device 4000 can have a power supply 4210, one or more input devices 4220, a central controller 4230, a therapy device controller 4240, a pressure generator 4140, one or more protection circuits 4250, a memory 4260, a transducer 4270, a data communication interface 4280, and one or more output devices 4290. The electrical components 4200 can be mounted on a single printed circuit board assembly (PCBA) 4202. In an alternative, the RPT device 4000 can include more than one PCBA 4202.

[0240] 5.4.1 RPT Device Mechanical and Pneumatic Components The RPT device may include one or more of the following components in an integral unit: In one alternative, one or more of the following components may be disposed as their own separate units.

[0241] 5.4.1.1 Air filter(s) An RPT device according to one form of the present technology may include an air filter 4110 or multiple air filters 4110.

[0242] In one form, the inlet air filter 4112 is positioned at the beginning of the air pressure path upstream of the pressure generator 4140 .

[0243] In one form, an outlet air filter 4114 (eg, antibacterial factor) is located between the outlet of the pneumatic block 4020 and the patient interface 3000.

[0244] 5.4.1.2 Muffler(s) An RPT device according to one form of the present technology may include a muffler 4120 or multiple mufflers 4120.

[0245] In one form of the present technology, an inlet muffler 4122 is positioned above a pressure generator 4140 in the pneumatic path.

[0246] In one form of the present technology, the outlet muffler 4124 is positioned in the pneumatic path between the pressure generator 4140 and the patient interface 3000.

[0247] 5.4.1.3 Pressure generator In one form of the present technology, the pressure generator 4140 that generates the air flow or supply at positive pressure is a controllable blower 4142. For example, the blower 4142 may include a brushless DC motor 4144 with one or more impellers. The impellers may be disposed within a volute. The blower may deliver the air supply at a rate of, for example, up to about 120 liters / min, at a positive pressure ranging from about 4 cmH2O to about 20 cmH2O, or in other forms up to about 30 cmH2O. The blower may be described in any one of the following patents or patent applications, which are incorporated herein by reference in their entirety: U.S. Pat. No. 7,866,944; U.S. Pat. No. 8,638,014; U.S. Pat. No. 8,636,479; and PCT Patent Application Publication WO 2013 / 020167.

[0248] The pressure generator 4140 is under the control of the treatment device controller 4240 .

[0249] In other forms, pressure generator 4140 can be a piston-driven pump, a pressure regulator connected to a high pressure source (eg, a compressed air reservoir), or a bellows.

[0250] 5.4.1.4 Converters The transducer may be internal to the RPT device or external to the RPT device. An external transducer may, for example, be located on the air circuit or form part of the air circuit (e.g., a patient interface). An external transducer may take the form of a non-contact sensor (e.g., a Doppler radar motion sensor that transmits or moves data RPT device).

[0251] In one form of the present technology, one or more transducers 4270 may be positioned upstream and / or downstream of the pressure generator 4140. The one or more transducers 4270 may be constructed and arranged to generate a signal indicative of a characteristic of the airflow (e.g., flow rate, pressure or temperature at that point in the pneumatic path).

[0252] In one form of the present technology, one or more transducers 4270 may be positioned proximate the patient interface 3000.

[0253] In one form, the signal from the converter 4270 may be filtered (eg, by low-pass, high-pass or band-pass filtering).

[0254] 5.4.1.4.1 Flow Sensors A flow sensor 4274 according to the present technology may be based on a differential pressure transducer (eg, an SDP600 series differential pressure transducer from SENSIRION).

[0255] In one form, a signal indicative of the flow rate from the flow sensor 4274 is received by the central controller 4230.

[0256] 5.4.1.4.2 Pressure Sensors A pressure sensor 4272 according to the present technology can be placed in fluid communication with the pneumatic path. One example of a suitable pressure sensor is a transducer from the HONEYWELL ASDX series. Another suitable pressure sensor is a transducer from the NPA series from GENERAL ELECTRIC.

[0257] In one form, the signal from the pressure sensor 4272 is received by the central controller 4230. 5.4.1.4.3 Motor Speed ​​Converters

[0258] In one form of the present technology, a motor speed transducer 4276 may be used to determine the rotational speed of the motor 4144 and / or the blower 4142. A motor speed signal from the motor speed transducer 4276 may be provided to the therapy device controller 4240. The motor speed transducer 4276 may be, for example, a speed sensor (e.g., a Hall effect sensor).

[0259] 5.4.1.5 Anti-spillback valves In one form of the present technology, an anti-spillback valve 4160 may be disposed between the humidifier 5000 and the pneumatic block 4020. The anti-spillback valve is constructed and positioned to reduce the risk of water flowing upstream from the humidifier 5000 (e.g., to the blower motor 4144).

[0260] 5.4.2 RPT Device Electrical Components 5.4.2.1 Power supply The power supply 4210 may be located inside or outside the external housing 4010 of the RPT device 4000.

[0261] In one form of the present technology, the power supply 4210 powers only the RPT device 4000. In another form of the present technology, power is provided from the power supply 4210 to both the RPT device 4000 and the humidifier 5000.

[0262] 5.4.2.2 Input Devices In one form of the present technology, the RPT device 4000 includes one or more input devices 4220 in the form of buttons, switches or dials to allow a human to interact with the device. The buttons, switches or dials may be physical or software devices accessible via a touch screen. The buttons, switches or dials may be physically connected to the external housing 4010 in one form or may communicate wirelessly with a receiver electrically connected to the central controller 4230 in another form.

[0263] In one form, the input device 4220 may be constructed and arranged to allow a human to select values ​​and / or menu options.

[0264] 5.4.2.3 Central Controller In one form of the present technology, the central controller 4230 is one or more processors suitable for controlling the RPT device 4000.

[0265] Suitable processors may include x86 INTEL processors, such as processors based on the ARM® Cortex®-M processor from ARM Holdings (e.g., the S®32 series of microcontrollers from ST Microelectronics). In certain alternative forms of the present technology, 32-bit RISC CPUs (e.g., the STR9 series of microcontrollers from ST Microelectronics) or 16-bit RISC CPUs (e.g., processors from the MSP430 family of microcontrollers manufactured by TEXAS INSTRUMENTS) may also be suitable.

[0266] In one form of the present technology, the central controller 4230 is a dedicated electronic circuit.

[0267] In one form, the central controller 4230 is an application specific integrated circuit. In another form, the central controller 4230 includes discrete electronic components.

[0268] The central controller 4230 may be configured to receive input signals from one or more transducers 4270, one or more input devices 4220 and the humidifier 5000.

[0269] The central controller 4230 may be configured to provide output signal(s) to one or more of the output device 4290, the therapy device controller 4240, the data communication interface 4280, and the humidifier 5000.

[0270] In some forms of the present technology, the central controller 4230 is configured to implement one or more methods described herein (e.g., one or more algorithms 4300 expressed as a computer program stored in a non-transitory computer readable recording medium (e.g., memory 4260)). In some forms of the present technology, the central controller 4230 may be integrated with the RPT device 4000. However, in some forms of the present technology, some methods may be performed by a remotely located device. For example, the remotely located device may determine ventilator control settings or detect breathing-related events by analysis of recorded data (e.g., from any of the sensors described herein).

[0271] 5.4.2.4 Clock The RPT device 4000 may include a clock 4232 connected to the central controller 4230 .

[0272] 5.4.2.5 Therapy Device Controller In one form of the present technology, the therapy device controller 4240 is a therapy control module 4330 and forms part of the algorithms 4300 executed by the central controller 4230.

[0273] In one form of the present technology, the therapy device controller 4240 is a dedicated motor control integrated circuit. For example, in one form, the MC33035 brushless DC motor controller manufactured by ONSEMI is used.

[0274] 5.4.2.6 Protection circuit The one or more protection circuits 4250 in accordance with the present technology may include electrical protection circuits, temperature and / or pressure safety circuits.

[0275] 5.4.2.7 Memory In accordance with one form of the present technology, the RPT device 4000 includes a memory 4260 (e.g., non-volatile memory). In some forms, the memory 4260 may include battery-powered static RAM. In some forms, the memory 4260 may include volatile RAM.

[0276] The memory 4260 may be located on the PCBA 4202. The memory 4260 may take the form of an EEPROM or a NAND flash.

[0277] Additionally or alternatively, the RPT device 4000 includes removable memory 4260 (eg, a memory card made in accordance with the Secure Digital (SD) standard).

[0278] In one form of the present technology, the memory 4260 functions as a non-transitory computer-readable storage medium on which are stored computer program instructions embodying one or more of the methods described herein (e.g., one or more algorithms 4300).

[0279] 5.4.2.8 Data communication systems In one form of the present technology, a data communications interface 4280 is provided and connected to the central controller 4230. The data communications interface 4280 may be connectable to a remote external communications network 4282 and / or a local external communications network 4284. The remote external communications network 4282 may be connectable to a remote external device 4286. The local external communications network 4284 may be connectable to a local external device 4288.

[0280] In one form, the data communications interface 4280 is part of the central controller 4230. In another form, the data communications interface 4280 is separate from the central controller 4230 and may include an integrated circuit or processor.

[0281] In one form, the remote external communications network 4282 is the Internet. The data communications interface 4280 may use wired communications (e.g., via Ethernet or fiber optics) or may use wireless protocols (e.g., CDMA, GSM, LTE) to connect to the Internet.

[0282] In one form, the local external communications network 4284 uses one or more communications standards (eg, Bluetooth or Consumer Infrared Protocol).

[0283] In one form, the remote external device 4286 is one or more computers (e.g., a cluster of networked computers). In one form, the remote external device 4286 may be a virtual computer rather than a physical computer. In either case, such a remote external device 4286 may be accessible by an appropriately authorized person (e.g., a clinician).

[0284] The local external device 4288 may be a personal computer, a cell phone, a tablet or a remote control.

[0285] 5.4.2.9 Optional displays and output devices, including alarms Output devices 4290 according to the present technology may take the form of one or more of visual, audio and tactile units. The visual display may be a Liquid Crystal Display (LCD) or a Light Emitting Diode (LED) display.

[0286] 5.4.2.9.1 Display Drivers The display driver 4292 receives as input characters, symbols or images to be displayed on the display 4294 and converts them into commands that cause the display 4294 to display those characters, symbols or images.

[0287] 5.4.2.9.2 Display The display 4294 is configured to visually display characters, symbols, or images in response to commands received from the display driver 4292. For example, the display 4294 may be an eight-segment display, in which case the display driver 4292 converts each character or symbol (e.g., the number "0") into eight logic signals indicating which of the eight segments should be activated to display the particular character or symbol.

[0288] 5.5 Air Circuit An air circuit 4170, according to one aspect of the present technology, is a conduit or tube constructed and arranged such that, in use, air flow travels between two components (eg, the RPT device 4000 and the patient interface 3000).

[0289] In particular, the air circuit 4170 may be fluidly connected to the outlet of the pneumatic block 4020 and the patient interface. The air circuit may be referred to as an air delivery tube. In some cases, there may be separate limbs of the circuit for inhalation and exhalation. In other cases, a single limb is used.

[0290] In some forms, the air circuit 4170 may include one or more heating elements configured to heat the air in the air circuit (e.g., to maintain or increase the air temperature). The heating elements may take the form of a heated wire circuit and may include one or more transducers (e.g., temperature sensors). In one form, the heated wire circuit may be spirally wound around the axis of the air circuit 4170. The heating elements may be in communication with a controller (e.g., central controller 4230). One example of an air circuit 4170 including a heated wire circuit is described in U.S. Patent Application No. 8,733,349, which is incorporated by reference in its entirety.

[0291] 5.5.1 Oxygen delivery In one form of the present technology, supplemental oxygen 4180 can be delivered to one or more points in the pneumatic pathway (eg, upstream of the pneumatic block 4020), the pneumatic circuit 4170 and / or the patient interface 3000.

[0292] 5.6 Humidifier 5.6.1 Humidifier Overview In one form of the present technology, a humidifier 5000 is provided for changing the absolute humidity of air or gas to be delivered to a patient relative to the ambient air (e.g., as shown in FIG. 5A). Typically, the humidifier 5000 is used to increase the absolute humidity (relative to ambient air) and increase the temperature of the air stream before delivery to the patient's airway.

[0293] The humidifier 5000 may include a humidifier reservoir 5110, a humidifier inlet 5002 for receiving an airflow, and a humidifier outlet 5004 for delivering a humidified airflow. In some forms, such as shown in Figures 5A and 5B, the inlet and outlet of the humidifier reservoir 5110 may be the humidifier inlet 5002 and the humidifier outlet 5004, respectively. The humidifier 5000 may further include a humidifier base 5006. The humidifier base 5006 may be adapted to receive the humidifier reservoir 5110 and may include a heating element 5240.

[0294] 5.6.2 Humidifier Components 5.6.2.1 Water reservoir According to one arrangement, the humidifier 5000 may include a water reservoir 5110 configured to contain or hold a quantity of liquid (e.g., water) to be evaporated for humidification of the airflow. The water reservoir 5110 may be configured to contain a predetermined maximum quantity of water to provide adequate humidification for at least the duration of a respiratory therapy session (e.g., a night's sleep). Typically, the reservoir 5110 is configured to contain several hundred milliliters of water (e.g., 300 milliliters (ml), 325 ml, 350 ml, or 400 ml). In another form, the humidifier 5000 may be configured to receive a water supply from an external water source (e.g., a building's water supply system).

[0295] According to one embodiment, the water reservoir 5110 is configured to humidify the air flow from the RPT device 4000 as the air flow passes through the RPT device 4000. In one form, the water reservoir 5110 may be configured to promote the air flow traveling a tortuous path through the reservoir 5110 while the air flow contacts a volume of water in the reservoir 5110.

[0296] According to one form, the reservoir 5110 may be removable from the humidifier 5000 laterally, for example as shown in Figures 5A and 5B.

[0297] The reservoir 5110 may also be configured to inhibit liquid release from the reservoir 5110, for example, when the reservoir 5110 is displaced and / or rotated from its normal operating orientation (e.g., through any aperture and / or between its subcomponents). Because the air flow to be humidified by the humidifier 5000 is often pressurized, the reservoir 5110 may also be configured to prevent loss of air pressure through leakage and / or flow impedance.

[0298] 5.6.2.2 Conductive Sites According to one arrangement, the reservoir 5110 includes a conductive region 5120 configured to allow efficient heat transfer from the heating element 5240 to the volume of liquid in the reservoir 5110. In one form, the conductive region 5120 may be arranged as a plate, although other shapes may be suitable. All or part of the conductive region 5120 may be constructed of a thermally conductive material such as aluminum (e.g., approximately 2 mm (e.g., 1 mm, 1.5 mm, 2.5 mm, or 3 mm) thick), another thermally conductive metal, or some plastic. In some cases, adequate thermal conductivity may be achieved with a less conductive material of appropriate geometry.

[0299] 5.6.2.3 Humidifier Reservoir Dock In one form, the humidifier 5000 may include a humidifier reservoir dock 5130 (as shown in FIG. 5B) configured to receive the humidifier reservoir 5110. In some arrangements, the humidifier reservoir dock 5130 may include a locking feature (e.g., a locking lever 5135 configured to hold the reservoir 5110 within the humidifier reservoir dock 5130).

[0300] 5.6.2.4 Water Level Indicator The humidifier reservoir 5110 may include a water level indicator 5150 as shown in Figures 5A-5B. In some forms, the water level indicator 5150 may provide one or more indications to a user, such as the patient 1000 or a caregiver, about the amount of water in the humidifier reservoir 5110. The one or more indications provided by the water level indicator 5150 may include an indication of a maximum predetermined amount of water, any portion thereof (e.g., 25%, 50% or 75% or an amount (e.g., 200ml, 300ml or 400ml)).

[0301] 5.6.2.5 Humidifier Transducer(s) The humidifier 5000 may include one or more humidifier transducers (sensors) 5210 instead of or in addition to the transducers 4270 described above. The humidifier transducers 5210 may include one or more of an air pressure sensor 5212, an air flow transducer 5214, a temperature sensor 5216, or a humidity sensor 5218 as shown in FIG. 5C. The humidifier transducers 5210 may generate one or more output signals. These output signals may be communicated to a controller (e.g., the central controller 4230 and / or the humidifier controller 5250). In some forms, the humidifier transducers may be located outside the humidifier 5000 (e.g., within the air circuit 4170) while communicating the output signals to the controller.

[0302] 5.6.2.5.1 Pressure transducers One or more pressure transducers 5212 may be provided to the humidifier 5000 in addition to or instead of the pressure sensor 4272 provided in the RPT device 4000.

[0303] 5.6.2.5.2 Flow Converters In addition to or instead of the flow sensor 4274 provided in the RPT device 4000, one or more flow transducers 5214 may be provided to the humidifier 5000.

[0304] 5.6.2.5.3 Temperature Converters The humidifier 5000 may include one or more temperature transducers 5216. The one or more temperature transducers 5216 may be configured to measure one or more temperatures (e.g., the temperature of the heating element 5240 and / or the temperature of the air flow downstream of the humidifier outlet 5004). In some forms, the humidifier 5000 may further include a temperature sensor 5216 that detects the temperature of the ambient air.

[0305] 5.6.2.5.4 Humidity Transducers In one form, the humidifier 5000 may include one or more humidity sensors 5218 that detect the humidity of a gas, such as ambient air. In some forms, the humidity sensor 5218 may be positioned toward the humidifier outlet 5004 to measure the humidity of the gas delivered from the humidifier 5000. The humidity sensor may be an absolute humidity sensor or a relative humidity sensor.

[0306] 5.6.2.6 Heating elements In some cases, a heating element 5240 may be provided to the humidifier 5000 to provide heat input to one or more of the volume of water in the humidifier reservoir 5110 and / or the volume of water to the airflow. The heating element 5240 may include a heat-generating component, such as an electrical resistance heating track. One suitable example of the heating element 5240 is a layered heating element, for example, as described in PCT Patent Application Publication No. WO2012 / 171072, the entirety of which is incorporated herein by reference.

[0307] In some forms, the heating element 5240 may be mounted in the humidifier base 5006. In the humidifier base 5006, heat may be transferred to the humidifier reservoir 5110 primarily by conduction, as shown in FIG.

[0308] 5.6.2.7 Humidifier Controller According to one arrangement of the present technology, the humidifier 5000 may include a humidifier controller 5250 as shown in FIG. 5C. In one form, the humidifier controller 5250 may be part of the central controller 4230. In another form, the humidifier controller 5250 may be a separate controller that may be in communication with the central controller 4230.

[0309] In one form, the humidifier controller 5250 may receive measurements of characteristics (e.g., temperature, humidity, pressure and / or flow rate) as inputs (e.g., measurements of airflow, water in the reservoir 5110 and / or in the humidifier 5000). The humidifier controller 5250 may also be configured to run or implement a humidifier algorithm and / or deliver one or more output signals.

[0310] As shown in FIG. 5C, the humidifier controller 5250 may include one or more controllers (e.g., a central humidifier controller 5251, a heated air circuit controller 5254 configured to control the temperature of the heated air circuit 4171, and / or a heating element controller 5252 configured to control the temperature of the heating element 5240).

[0311] 5.7 Respiratory waveform FIG. 6 shows a model of a typical human respiratory waveform during sleep. The horizontal axis is time and the vertical axis is respiratory flow. Since parameter values ​​can vary, a typical breath can have the following approximate values: tidal volume, Vt, 0.5L; inhalation time, Ti, 1.6 seconds; peak inhalation flow, Qpeak, 0.4L / sec; exhalation time, Te, 2.4s; peak expiratory flow, Qpeak, -0.5L / sec. The total duration of the breath, Ttot, is about 4 seconds. Humans typically breathe about 15 times per minute (BPM) and the ventilation, Vent, is about 7.5L / min. A typical duty cycle, the ratio of Ti to Ttot, is about 40%.

[0312] 5.8 Glossary For purposes of this disclosure, in certain aspects of the technology, one or more of the following definitions may apply. In other aspects of the technology, other definitions may apply.

[0313] 5.8.1 General Air: In certain forms of the present technology, air may refer to atmospheric air, while in other forms of the present technology, air may refer to combinations of other breathable gases (e.g., oxygen-rich atmospheric air).

[0314] Atmosphere: In certain forms of the present technology, the term "atmosphere" should be taken to mean: (i) that which is external to the treatment system or patient, and (ii) that which immediately surrounds the treatment system or patient.

[0315] For example, the ambient humidity for a humidifier may be the humidity of the air immediately surrounding the humidifier (e.g., the humidity inside the room in which the patient sleeps). Such ambient humidity may differ from the humidity outside the room in which the patient sleeps.

[0316] In another example, the atmospheric pressure may be the pressure immediately surrounding or external to the body.

[0317] In certain embodiments, ambient (e.g., acoustic) noise can be considered the background noise level in the room the patient is in, other than noise emanating from, for example, the RPT device or from the mask or patient interface. Ambient noise can originate from sources outside the room.

[0318] Automatic Positive Airway Pressure (APAP) Therapy: A CPAP therapy that is capable of automatically adjusting therapeutic pressure between minimum and maximum limits, for example, between breaths, depending on the presence or absence of signs of an SDB episode.

[0319] Continuous Positive Airway Pressure (CPAP) Therapy: Respiratory pressure therapy in which the therapeutic pressure is approximately constant throughout the patient's respiratory cycle. In some forms, the pressure at the entrance to the airway increases slightly during expiration and decreases slightly during inspiration. In some forms, the pressure varies during different respiratory cycles of the patient (e.g., increased in response to detection of an indication of partial upper airway obstruction and decreased in the absence of notification of partial upper airway obstruction).

[0320] Flow Rate: The instantaneous amount (or mass) of air delivered per unit time. Flow rate may refer to an instantaneous quantity. In some cases, references to flow rate refer to a scalar quantity (i.e., a quantity that has only magnitude). In other cases, references to flow rate refer to a vector quantity (i.e., a quantity that has both magnitude and direction). Flow rate may be given the symbol Q. "Flow rate" may also be called "flow" or "airflow" for shorthand.

[0321] In the example of a patient's breath, the flow rate may be nominally positive for the inhalation portion of the patient's breathing cycle, and therefore negative for the exhalation portion of the patient's breathing cycle. Total flow rate Qt is the flow rate of air exiting the RPT device. Ventilator flow rate Qv is the flow rate of air exiting the vent to allow for the outflow of exhaled gases. Leakage flow rate Ql is the flow rate of leakage from the patient interface system or elsewhere. Respiratory flow rate Qr is the flow rate of air received into the patient's respiratory system.

[0322] Humidifier: The word "humidifier" is to be construed as meaning a humidification device constructed, arranged or configured with a physical structure capable of providing a therapeutically beneficial quantity of water (H2O) vapor to an air stream to improve the medical respiratory condition of a patient.

[0323] Leakage: The term "leakage" is taken as an unintended air flow. In one embodiment, a leak may occur due to an imperfect seal between the mask and the patient's face. In another embodiment, a leak may occur at the elbow to the perimeter.

[0324] Noise Conduction (Acoustic): In this document, conducted noise refers to noise that is carried to the patient by the pneumatic pathway (e.g., the air circuit and the patient interface and the air therein). In one form, conducted noise can be quantified by measuring the sound pressure level at the end of the air circuit.

[0325] Noise Emission (Acoustic): In this document, radiated noise refers to noise that is carried by the surrounding air to the patient. In one form, radiated noise can be quantified by measuring the sound power / pressure level of the target according to ISO 3744.

[0326] Ventilation Noise (Acoustic): In this document, ventilation noise refers to the noise generated by airflow through any vents (eg, vent holes in the patient interface).

[0327] Patient: A person with or without respiratory disease.

[0328] Pressure: force per unit area. Pressure can be expressed in a variety of units (e.g., cmH2O, gf / cm 2 , and hectopascals). 1cmH2O is 1g-f / cm 2 which is approximately 0.98 hectopascals. In this specification, pressure is given in units of cmH2O unless otherwise specified.

[0329] The pressure in the patient interface is given the symbol Pm, and the therapeutic pressure, which represents the target value that the mask pressure Pm should achieve at this moment, is given the symbol Pt.

[0330] Respiratory Pressure Therapy (RPT): The application to the airway inlet of an air supply at therapeutic pressure, typically a positive pressure relative to the atmosphere.

[0331] Ventilator: A mechanical device that provides pressure support to a patient during some or all of the work of breathing.

[0332] 5.8.1.1 Materials Silicone or Silicone Elastomer: Synthetic rubber. In this specification, when silicone is mentioned, it refers to liquid silicone rubber (LSR) or compression molded silicone rubber (CMSR). One form of commercially available LSR is SILASTIC (in a family of products sold under this trademark) manufactured by Dow Corning. Another LSR manufacturer is Wacker. Unless otherwise specified to the contrary, exemplary forms of LSR have a Shore A (or Type A) indentation hardness of about 35 to about 45 as measured by ASTM D2240.

[0333] Polycarbonate: A thermoplastic polymer of bisphenol A carbonate.

[0334] 5.8.1.2 Mechanical properties Elasticity: The ability of a material to absorb energy during elastic deformation and to release the energy when unloaded.

[0335] Elastic: Releases substantially all of the energy upon unloading. Examples include certain silicone and thermoplastic elastomers.

[0336] Hardness: The ability of a material to resist deformation within itself (as described, for example, by Young's Modulus or the indentation hardness scale measured over a standardized sample size). "Soft" materials may include silicone or thermoplastic elastomers (TPEs), and may deform easily under finger pressure, for example. "Hard" materials may include polycarbonate, polypropylene, steel or aluminum, and do not easily deform under finger pressure, for example.

[0337] Stiffness (or rigidity) of a structure or component: The ability of a structure or component to resist deformation when subjected to a load. The load can be a force or a moment (e.g., compression, extension, bending, or torsion). A structure or component may offer different resistance in different directions.

[0338] Floppy Structure or Component: A structure or component that changes shape (e.g., flexes) within a relatively short period of time (e.g., 1 second) when forced to support its own weight.

[0339] Rigid Structure or Component: A structure or component that does not substantially change shape when subjected to loads typically encountered in use. An example of such an application may be setting up and maintaining a patient interface in a sealed manner against a patient airway entrance under a pressure load of, for example, approximately 20-30 cmH2O.

[0340] As one example, an I-beam may include a different bending stiffness (resistance to bending load) in a first direction compared to a second, orthogonal direction, hi another example, a structure or component may be floppy in a first direction and stiff in a second direction.

[0341] 5.8.2 Breathing cycle Apnea: According to some definitions, apnea is said to occur when flow below a certain threshold continues for a duration of, for example, 10 seconds. Obstructive apnea is said to occur when some airway obstruction does not allow airflow despite patient effort. Central apnea is said to refer to a condition in which apnea is detected due to reduced or absent respiratory effort despite a patent airway. Mixed apnea is said to refer to a condition in which reduced or absent respiratory effort occurs simultaneously with airway obstruction.

[0342] Respiratory Rate: The patient's spontaneous breathing rate, usually measured in breaths per minute.

[0343] Duty Cycle: The ratio of inspiration time Ti to total breathing time Ttot.

[0344] Effort (Respiration): Respiratory effort is said to refer to the movement made by a person's spontaneous breathing in an attempt to breathe.

[0345] Expiratory portion of the respiratory cycle: the period from the start of the expiratory flow to the start of the inspiratory flow.

[0346] Flow limitation: Flow limitation is understood to be a situation in a patient's breathing where an increase in effort by the patient does not cause a corresponding increase in flow. If the flow limitation occurs during the inhalation portion of the respiratory cycle, the flow limitation may be referred to as inhalation flow limitation. If the flow limitation occurs during the exhalation portion of the respiratory cycle, the flow limitation may be referred to as expiratory flow limitation.

[0347] Flow-limited inspiration waveform types: (i) Flattening: An upswing followed by a relatively flat area and then a downswing. (ii) M-shaped: has two local peaks, one at the leading edge and one at the trailing edge, with a relatively flat region between the two peaks. (iii) Chair-like: Has a single local peak that occurs at the rising edge and is followed by a relatively flat region. (iv) Inverted chair shape: A relatively flat region is followed by a single local peak, which occurs on the trailing edge.

[0348] Hypopnea: By some definitions, hypopnea refers to a reduction in flow, rather than an interruption of flow. In one form, hypopnea is said to occur when there is a sustained period of reduced flow below a threshold rate. When hypopnea is detected due to a reduction in respiratory effort, central hypopnea is said to occur. In one form in adults, hypopnea may be considered when any of the following occur: (i) A 30% decrease in patient respiration for at least 10 seconds plus an associated 4% desaturation, or (ii) A reduction in patient respiration (less than 50%) lasting for at least 10 seconds and associated with at least 3% desaturation or arousal occurs.

[0349] Hyperventilation: An increase in flow to a level higher than normal.

[0350] Inspiration portion of the respiratory cycle: The period from the start of the inspiratory flow to the start of the expiratory flow is taken as the inspiration portion of the respiratory cycle.

[0351] Patency (Airway): The degree to which the airway is open or the extent to which the airway is open. Airway patency is an opening. Airway patency may be quantified, for example, with a value of 1 indicating open and a value of 0 indicating closed (obstructed).

[0352] Positive end-expiratory pressure (PEEP): The pressure above atmosphere in the lungs that exists at the end of expiration.

[0353] Peak flow (Qpeak): The maximum value of flow during the inspiratory portion of the respiratory flow waveform.

[0354] Respiratory airflow, airflow, patient airflow, respiratory airflow (Qr): these terms may be understood to refer to the RPT device's estimate of respiratory airflow and are used in contrast to "true respiratory flow" or "true respiratory airflow", which is the patient's actual respiratory flow, usually expressed in liters / minute.

[0355] Tidal volume (Vt): The volume of air inhaled or exhaled during normal breathing without extra effort. In principle, the inhaled volume Vi (volume of air inhaled) is equal to the exhaled volume Ve (volume of air exhaled), so a single tidal volume Vt can be defined as equal to either volume. In practice, the tidal volume Vt is estimated as some combination (e.g., the average of the inhaled volume Vi and the exhaled volume Ve).

[0356] (Inspiration) Time (Ti): The duration of the inspiratory portion of the respiratory flow waveform.

[0357] (Expiratory) Time (Te): The duration of the expiratory portion of the respiratory flow waveform.

[0358] (Total) Time (Ttot): The total duration between the start of one inspiratory portion of the respiratory flow waveform and the start of the next inspiratory portion of the respiratory flow waveform.

[0359] Typical Recent Ventilation: The ventilation value around which the most recent values ​​of ventilationVent tend to cluster over a given time scale (i.e., the degree to which the most recent values ​​of ventilation tend to be central).

[0360] Upper Airway Obstruction (UAO): Includes both partial and total upper airway obstruction. Can be associated with a state of flow limitation in which flow may increase or decrease slightly with increasing pressure differential across the upper airway (Starling resistor behavior).

[0361] Vent: A measurement of the rate of gas exchange performed by a patient's respiratory system. Measurements of ventilation may include either or both inhaled and exhaled airflow per unit of time. When expressed as volume per minute, this amount is often referred to as "minute ventilation." Minute ventilation is sometimes simply given as volume and is understood as volume per minute.

[0362] 5.8.3 Ventilation Adaptive servo-ventilator (ASV): A servo-ventilator that does not have a fixed target ventilation, but rather is variable. The variable target ventilation can be learned from some characteristics of the patient (e.g., the patient's breathing characteristics).

[0363] Backup Rate: A ventilator parameter that establishes the minimum respiratory rate (typically in breaths per minute) that will be delivered from the ventilator to the patient (when not triggered by spontaneous breathing efforts).

[0364] Cycle: The end of the inspiratory phase of a ventilator. When a ventilator delivers breaths to a spontaneously breathing patient, at the end of the inspiratory portion of the breathing cycle, the ventilator is said to be cycled to stop breath delivery.

[0365] Expiratory Positive Airway Pressure (EPAP): The base pressure to which varying pressure is added within a breath to produce the desired mask pressure the ventilator is attempting to achieve at a given time.

[0366] End Expiratory Pressure (EEP): The desired mask pressure that the ventilator attempts to achieve at the end of the expiratory portion of the breath. If the pressure waveform template Π(Φ) has a value of zero at the end of expiration (i.e., Π(Φ)=0 when Φ=1), then EEP is equal to EPAP.

[0367] Inspiratory Positive Airway Pressure (IPAP): The maximum desired mask pressure that the ventilator attempts to achieve during the inspiratory portion of the breath.

[0368] Pressure Support: A number indicating the increase in pressure during ventilator inhalation followed by exhalation of the same ventilator, and generally refers to the pressure difference between the maximum inhalation pressure and the base pressure (e.g., PS=IPAP-EPAP). In some contexts, pressure support refers to the difference the ventilator tries to achieve (rather than the difference it actually achieves).

[0369] Servo-ventilator: a ventilator that has patient ventilation and has target ventilation, and adjusts the level of pressure support to approximate the patient ventilation to the target ventilation.

[0370] Spontaneous / Timed (S / T): A mode of a ventilator or other device that attempts to detect the onset of a breath in a spontaneously breathing patient. However, if the device fails to detect a breath within a predetermined period of time, the device automatically begins breath delivery.

[0371] Swing: A term equivalent to pressure assistance.

[0372] Triggered: When a ventilator delivers a breath of air to a spontaneously breathing patient, the ventilator is said to be triggered to deliver a breath when the patient himself initiates the breathing portion of the breathing cycle.

[0373] 5.8.4 Anatomy 5.8.4.1 Facial Anatomy Ala: The outer wall or "wing" of each nostril (plural: alar)

[0374] Alare: The outermost point on the ala of the nose.

[0375] Alar curvature (or alar crest) point: The most posterior point on the curved baseline of each ala, found in the crease formed by the union of the ala and cheek.

[0376] Pinna: the entire visible part of the ear.

[0377] (Nasal) Skeleton: The nasal skeleton includes the nasal bones, the frontal process of the maxilla, and the nasal part of the frontal bone.

[0378] (Nasal) Cartilaginous folds: The nasal cartilaginous folds include the septal cartilage, lateral cartilage, greater cartilage and lesser cartilage.

[0379] Columella: The piece of skin that separates the nostrils and extends from the tip of the nose to the upper lip.

[0380] Columella angle: the angle between a line drawn through the midpoint of the nostrils and a line drawn perpendicular to the Frankfurt horizontal intersecting the subnasal point.

[0381] Frankfort horizontal plane: A line extending from the inferiormost point of the orbital rim to the left auricular point, which is the deepest point above the notch to the tragus of the pinna.

[0382] Glabellar: Located in the soft tissue, the most prominent point on the midsagittal portion of the forehead.

[0383] Lateral nasal cartilage: A generally triangular plate of cartilage whose upper margin is attached to the nasal bone and the frontal process of the maxilla and whose lower margin is connected to the greater alar cartilage.

[0384] Alar cartilage: a plate of cartilage located below the lateral nasal cartilage. It curves around the anterior part of the nostril. Its posterior end is attached to the frontal process of the maxilla by a tough fibrous membrane containing three or four alar cartilages.

[0385] Nostrils (nose holes): roughly ellipsoidal alar openings that form the entrance to the nasal cavity. The singular form of nares is naris (nose hole). The nostrils are separated by the nasal septum.

[0386] Nasolabial fold or nasolabial crease: a fold or groove of skin that runs from each side of the nose to the corners of the mouth and separates the cheeks from the upper lip.

[0387] Nasolabial angle: the angle between the bridge of the nose and the upper lip, intersecting with the subnasal point.

[0388] Inferior ear point: lowest point of attachment of the pinna to the facial skin.

[0389] Superior auricular point: the highest point of attachment of the pinna to the facial skin.

[0390] Nasal tip: the most prominent point or tip of the nose, which can be seen in a lateral view of the rest of the head section.

[0391] Philtrum: midline groove extending from the lower border of the nasal septum to the top of the lip in the upper lip area.

[0392] Pogonion: The most anterior midpoint of the jaw, located on the soft tissue.

[0393] (Nasal) ridge: The nasal ridge is the midline prominence of the nose, extending from the serion to the apex.

[0394] Sagittal Plane: A vertical plane running from anterior (front) to posterior (back). The midsagittal plane is the sagittal plane that divides the body into right and left halves.

[0395] Cerion: Located on the soft tissue, it is the most concave point on the area of ​​the frontonasal suture.

[0396] Septal cartilage (nose): The nasal septal cartilage is part of the septum, which divides the anterior part of the nasal cavity.

[0397] Nasal Alar Lowest Point: The point on the lower margin of the alar base where it joins with the skin of the upper (top) lip.

[0398] Subnasal point: located on the soft tissue where the columella joins the upper lip in the midsagittal direction.

[0399] Supramenton: The most concave point in the midline of the lower lip between the lower lip midpoint and the soft tissue pogonion.

[0400] 5.8.4.2 Skull anatomy Frontal bone: The frontal bone contains the large vertical portion, the scales frontalis, which correspond to the area known as the forehead.

[0401] Mandible: The mandible forms the lower jaw. The mental eminence is a bony protuberance in the jaw, forming the chin.

[0402] Maxilla: The maxilla forms the upper jaw and is located below the mandible and below the orbit. The frontal process of the maxilla projects upwards by the side of the nose and forms part of its lateral border.

[0403] Nasal bones: The nasal bones are two small rectangular bones that vary in size and shape from one individual to another. They lie side by side in the middle and upper parts of the face and their junction forms the "bridge" of the nose.

[0404] Nasion: the intersection of the frontal bone and the two nasal bones, a concave area directly between the eyes and the upper side of the bridge of the nose.

[0405] Occipital bone: The occipital bone is located at the back and lower part of the skull. It contains an oval hole, the foramen magnum, through which the intracranial cavity communicates with the vertebral canal. The curved plate posterior to the foramen magnum is the squama occipitalis.

[0406] Orbit: bony cavity in the skull that contains the eyeball.

[0407] Parietal bones: The parietal bones are the bones that, when joined together, form the top and sides of the skull.

[0408] Temporal Bone: The temporal bone is located at the base and on the side of the skull and supports parts of the face known as the temples.

[0409] Cheekbones: The two cheekbones in the face are located in the upper and outer parts of the face and form the cheek ridges.

[0410] 5.8.4.3 Respiratory system anatomy Diaphragm: A sheet of muscle that runs over the lower rib cage. It separates the thoracic cavity, which contains the heart, lungs, and ribs, from the abdominal cavity. When the diaphragm contracts, it increases the volume of the thoracic cavity and draws air into the lungs.

[0411] Larynx: The larynx or voice box that contains the vocal folds and connects the lower part of the pharynx (hypopharynx) to the trachea.

[0412] Lung: respiratory organ in humans. The conductive zone of the lung includes the trachea, bronchi, bronchiole, and terminal bronchioles. The respiratory zone includes the respiratory bronchioles, alveolar ducts, and alveoli.

[0413] Nasal Cavity: The nasal cavity (or nasal fossa) is a large air-filled space in the center of the face above and behind the nose. The nasal cavity is divided into two by a vertical fin called the nasal septum. On the sides of the nasal cavity are three horizontal extensions called the turbinates or nasal bones. At the front of the nasal cavity is the nose, and at the back it opens into the nasopharynx via the choanae.

[0414] Pharynx: The part of the throat located immediately below (inferior to) the nasal cavity and above the esophagus and larynx. The pharynx is traditionally divided into three parts: the nasopharynx (upper pharynx) (nasal part of the pharynx), the oropharynx (mid pharynx) (oral part of the pharynx), and the hypopharynx (low pharynx).

[0415] 5.8.5 Patient Interface Anti-asphyxiation valve (AAV): A component or subassembly of a mask system that reduces the risk of excessive rebreathing of CO2 by the patient by venting to atmosphere in a fail-safe manner.

[0416] Elbow: An elbow is an example of a structure that directs the axis of airflow moving therethrough to change direction through an angle. In one form, the angle may be approximately 90 degrees. In another form, the angle may be greater than or less than 90 degrees. The elbow may have a generally circular cross section. In another form, the elbow may have an oval or rectangular cross section. In certain forms, the elbow may be rotatable, for example, about 360 degrees, relative to the mating component. In certain forms, the elbow may be removable from the mating component, for example, via a snap connection. In certain forms, the elbow may be assembled to the mating component via a one-time snap at the time of manufacture, but cannot be removed by the patient.

[0417] Frame: Frame is taken to mean a mask structure that supports a tensile load between two or more points that connect the headgear. A mask frame may be a non-airtight load-bearing structure in the mask. However, some forms of mask frames may be airtight.

[0418] Headgear: Headgear is taken to mean a form of positioning and stabilizing structure designed to be used on the head. For example, the headgear may include a collection of one or more posts, ties and stiffeners configured to position and hold the patient interface in place on the patient's face for delivery of respiratory therapy. Some ties are formed from a soft, flexible, elastic material (e.g., a layered composite of foam and fabric).

[0419] Membrane: Membrane is taken to mean a typically thin-walled element, preferably offering substantially no resistance to bending and resistance to stretching.

[0420] Plenum Chamber: Mask plenum chamber is taken to mean a part of a patient interface having a wall that at least partially encloses a volume of space, the air in the volume being pressurized to exceed atmospheric pressure in use. The shell may form part of the wall of the mask plenum chamber.

[0421] Seal: When used as a noun ("seal") it can refer to a structure, and when used as a verb ("seal") it can refer to an effect. Two elements can be constructed and / or arranged to "seal" or achieve a "sealing" effect between them without the need for a separate "sealing" element itself.

[0422] Shell: A shell is taken to mean a curved, relatively thin structure that has bending, tensile and compressive stiffness. For example, the curved structural wall of a mask may be a shell. In some forms, the shell may be faceted. In some forms, the shell may be airtight. In some forms, the shell may not be airtight.

[0423] Stiffener: A stiffener is taken to mean a structural component designed to increase the bending stiffness of another component in at least one direction.

[0424] Strut: A strut is taken to mean a structural component designed to increase the compressive resistance of another component in at least one direction.

[0425] Swivel (noun): A subassembly of components configured to rotate, preferably independently, about a common axis, preferably under low torque. In one form, the swivel may be configured to rotate through an angle of at least 360 degrees. In another form, the swivel may be configured to rotate through an angle of less than 360 degrees. When used in the context of an air delivery conduit, the subassembly of components preferably includes a mating cylindrical conduit. In use, there is little leakage of air flow from the swivel.

[0426] Tie (noun): A structure designed to resist tension.

[0427] Vent: (noun): A structure that allows airflow to the ambient air inside a mask or conduit, allowing clinically effective flushing of exhaled gases. For example, flow rates of about 10 L / min to about 100 L / min may be used for clinically effective flushing, depending on mask design and treatment pressure.

[0428] 5.8.6 Shape of structure A product of the present technology may include one or more three-dimensional mechanical structures (e.g., a mask cushion or impeller). The three-dimensional structures may be bounded by two-dimensional surfaces. These surfaces may be differentiated with labels to describe the orientation, location, function or some other characteristic of the associated surfaces. For example, the structure may include one or more of a front surface, a back surface, an inner surface, and an outer surface. In another example, the seal-forming structure may include a face-contacting (e.g., outer) surface and a separate non-face-contacting (e.g., lower or inner) surface. In another example, the structure may include a first surface and a second surface.

[0429] To facilitate the description of the shape and surface of a three-dimensional structure, a cross section at a point p through the surface of the structure is first considered. See Figures 3B-3F. Figures 3B-3F show an example cross section at a point p on the surface, and an example of the resulting planar curve. Figures 3B-3F also show the outward normal vector at p. The outward normal vector at p points away from the surface. In some examples, the surface is described from the perspective of a fictional little person standing upright on the surface.

[0430] 5.8.6.1 Curvature in one dimension The curvature of a plane curve at p can be described as having a sign (eg, positive, negative) and a magnitude (eg, 1 / radius of the circle tangent to the curve at p).

[0431] Positive curvature: If the curve at p bends towards the outward normal, the curvature at that point is taken to have a positive value (if this imaginary little person walks away from point p, he or she would have to walk uphill). See Figure 3B (relatively large positive curvature compared to Figure 3C) and Figure 3C (relatively small positive curvature compared to Figure 3B). Such curves are often called concave.

[0432] Zero curvature: If the curve at p is a straight line, the curvature is taken as zero (if this imaginary little person walks away from point p, he can walk on a horizontal plane that is neither pointing up nor down). See Figure 3D.

[0433] Negative curvature: If the curve at p bends away from the outward normal, the curvature at that point and in that direction is taken to have a negative value (if this imaginary little person were to walk away from point p, he would have to walk downhill). See Figure 3E (relatively small negative curvature compared to Figure 3F) and Figure 3F (relatively large negative curvature compared to Figure 3E). Such curves are often called convex.

[0434] 5.8.6.2 Two-dimensional surface curvature The description of a shape at a given point on a two-dimensional surface according to the present technology may include multiple perpendicular cross sections. The multiple cross sections may cut the surface in a plane that includes the outward normal (the "normal plane"), and each cross section may be taken in a different direction. Each cross section results in a plane curve with a corresponding curvature. The different curvatures at the point may have the same sign or different signs. Each of the curvatures at the point has a (e.g., relatively small) magnitude. The plane curves in Figures 3B-3F may be examples of such multiple cross sections at a particular point.

[0435] Principal curvature and direction: The directions of the normal plane in which the curvature of the curve has a maximum and a minimum value are called the principal directions. In the example of Figures 3B-3F, the maximum curvature occurs in Figure 3B and the minimum occurs in Figure 3F, so Figures 3B and 3F are cross sections in the principal directions. The principal curvature at p is the curvature in the principal direction.

[0436] Surface region: A collection of connected points on a surface. This set of points within a region may have similar properties (e.g., curvature or sign).

[0437] Saddle region: a region where the principal curvatures at each point have opposite signs (i.e., one side has a positive sign and the other a negative sign) (depending on the direction a hypothetical person who may be walking uphill or downhill is facing).

[0438] Dome Area: A region where the principal curvatures at every point have the same sign: both positive ("concave dome") or both negative ("convex dome").

[0439] Cylindrical region: A region in which one principal curvature is zero (or zero, for example, within a manufacturing tolerance) and the other principal curvature is non-zero.

[0440] Planar Region: Region of a surface where both principal curvatures are zero (or are zero within a manufacturing tolerance, for example).

[0441] Surface Edge: the boundary or limit of a surface or area.

[0442] Path: In certain forms of the technology, a "path" is taken to mean a path in the mathematical-topological sense (e.g., a continuous space curve from f(0) to f(1) on a surface). In certain forms of the technology, a "path" may be described as a route or course that includes, for example, a set of points on a surface. (A fictional person's path is a place to walk on a surface, similar to a path in a garden.)

[0443] Path Length: In certain forms of the present technology, "path length" is taken to refer to the distance along a surface from f(0) to f(1) (i.e., the distance along a path on the surface). There may be more than one path between two points on a surface, and such paths may have different path lengths. (The path length of a fictional person is the distance walked along a path on the surface.)

[0444] Straight-line distance: Straight-line distance is the distance between two points on a surface, but does not take the surface into account. On a planar area, there is a distance on the surface edge that has the same path length as the straight-line distance between two points on the surface. On a non-planar surface, there cannot be a path that has the same path length as the straight-line distance between two points. (For a fictional person, straight-line distance corresponds to the distance "as the crow flies.")

[0445] 5.8.6.3 Space curve Space Curve: Unlike a plane curve, a space curve does not necessarily lie in any particular plane. A space curve may be closed, i.e., it has no end point. A space curve may be considered a one-dimensional piece of three-dimensional space. A fictional character walking on a strand of DNA helix walks along a space curve. A typical human left ear includes a left-handed helix (see FIG. 3Q). A typical human right ear includes a right-handed helix (see FIG. 3R). FIG. 3S shows a right-handed helix. The edge of a structure (e.g., the edge of a membrane or an impeller) may trace a space curve. In general, a space curve may be described by the curvature and twist at each point on the space curve. Twist is a measure of the way the curve emanates from the plane. Twist has a sign and a magnitude. The twist at a point on a space curve may be characterized with respect to the tangent, normal, and binormal vectors at that point.

[0446] Tangent unit vector (or unit tangent vector): For each point on a curve, the vector at that point specifies the direction and magnitude from that point. A tangent unit vector is a unit vector that points in the same direction as the curve at that point. If a fictional character was flying along a curve and fell off his vehicle at a particular point, the direction of the tangent vector is the direction he would be traveling.

[0447] Unit normal vector: If a fictional character is moving along a curve, this tangent vector itself changes. The unit vector that points in the same direction as the tangent vector is changing is called the unit principal normal vector. It is perpendicular to the tangent vector.

[0448] Binormal unit vector: The binormal unit vector is perpendicular to both the tangent vector and the principal normal vector. Its direction can be determined by the right-hand rule (see, for example, Figure 3P) or the left-hand rule (Figure 3O).

[0449] Tangent plane: the plane containing the unit tangent vector and the unit principal normal vector, see Figures 3O and 3P.

[0450] Torsion of a Space Curve: The torsion at a point of a space curve is the magnitude of the rate of change of the binormal unit vector at that point. It measures the degree of deviation of the curve from the tangential plane. The torsion of a space curve that lies within the plane is zero. If the space curve deviates from the tangential plane by a relatively small amount, the magnitude of torsion of the space curve is relatively small (e.g., a gently sloping spiral path). If the space curve deviates from the tangential plane by a relatively large amount, the magnitude of torsion of the space curve is relatively large (e.g., a steeply sloping spiral path). With reference to FIG. 3S, the magnitude of torsion of the neighbors of the top coil of the spiral in FIG. 3S is greater than the magnitude of torsion of the bottom coil of the spiral in FIG. 3S because T2>T1.

[0451] Referring to the right-hand rule in Figure 3P, a space curve that bends towards the right-hand binormal can be considered to have a positive twist in the right-hand direction (e.g., a right-hand spiral as shown in Figure 3S). A space curve that bends away from the right-hand binormal can be considered to have a negative twist in the right-hand direction (e.g., a left-hand spiral).

[0452] Similarly, with reference to the left-hand rule (see Figure 3O), a space curve with a left-handed binormal direction can be considered as having a left-handed positive twist (e.g., a left-handed spiral), where a left-handed positive direction thus corresponds to a right-handed negative direction, see Figure 3T.

[0453] 5.8.6.4 Holes A surface may have one-dimensional holes (e.g., holes bounded by a plane or space curve). In the case of a thin structure (e.g., a membrane) that contains holes, the structure may be described as having one-dimensional holes. See, for example, how the one-dimensional holes in the surface of the structure shown in Figure 3I are bounded by a plane curve.

[0454] A structure may have a two-dimensional hole (e.g., a hole bounded by a surface). For example, an inflatable tire has a two-dimensional hole bounded by the tire inner surface. In another example, a bladder with a cavity for air or gel may have a two-dimensional hole. See, for example, the cushion in FIG. 3L and the exemplary cross-section of FIG. 3L in FIG. 3M and FIG. 3N, where the inner surface bounding the two-dimensional hole is shown. In yet another example, a conduit may include a one-dimensional hole (e.g., at its inlet or its outlet) and may include a two-dimensional hole bounded by the inner surface of the conduit. See also the two-dimensional hole through the structure shown in FIG. 3K and bounded by a surface as shown.

[0455] 5.9 Other Notes Unless otherwise clearly indicated from the context and unless a range of values ​​is provided, it is understood that each intervening value between the upper and lower limits of the range, the unit of the lower limit, and any other stated or intervening value of the stated range is encompassed by the technology. The upper and lower limits of these intervening ranges, which are independently included in the intervening range, are also encompassed by the technology if they specifically exceed the limits in the stated range. If the stated range includes one or both of these limits, then ranges exceeding either or both of these stated limits are also encompassed by the technology.

[0456] Furthermore, when a value or values ​​are embodied herein as part of the present technology, unless otherwise indicated, it is understood that such values ​​may be approximated and may be used to any appropriate significant figures to the extent practical technical practice permits or requires.

[0457] Unless otherwise specified, all technical and scientific terms herein have the same meaning as commonly understood by one of ordinary skill in the art to which this technology belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of this technology, a limited number of exemplary methods and materials are described herein.

[0458] Although particular materials are described as being preferred for use in the construction of components, obvious alternative materials having similar properties may be substituted. Further, unless stated to the contrary, any and all components described herein are understood to be manufacturable and therefore may be manufactured collectively or separately.

[0459] Please note that as used herein and in the appended claims, the singular forms "a," "an," and "the" include their plural equivalents unless the context clearly dictates otherwise.

[0460] All publications mentioned herein are incorporated by reference to disclose and describe the methods and / or materials that are the subject of these publications. Publications mentioned herein are provided solely for their disclosure prior to the filing date of this application. Nothing herein should be construed as an admission that the present technology does not antedate such publications by virtue of prior patents. Furthermore, the dates of publications mentioned may differ from the actual publication dates, which may require independent confirmation.

[0461] The terms "comprises" and "comprising" should be construed as referring to elements, components, or steps in a non-exclusive sense, indicating that a described element, component, or step may be present in, utilized with, or combined with other elements, components, or steps that are not specifically described.

[0462] The headings used in the detailed description are for the convenience of the reader and should not be used to limit the content found in the disclosure or claims as a whole. These headings should not be used in interpreting the scope of the claims or the limitations of the claims.

[0463] Although the technology herein has been described with reference to specific embodiments, it should be understood that these embodiments are merely illustrative of the principles and applications of the technology. In some cases, terms and symbols may indicate specific details that are not necessary for the practice of the technology. For example, the terms "first" and "second" (and the like) are used, but unless otherwise specified, these terms are not intended to indicate any order, but are used to distinguish separate elements. Furthermore, although the description or illustration of process steps in the method may be described in an order, such order is not required. Those skilled in the art will recognize that such order can be changed and / or aspects thereof can be performed simultaneously or even synchronously.

[0464] It is therefore to be understood that numerous modifications may be made in the illustrative embodiments and other arrangements may be devised without departing from the spirit and scope of the present technology. [Explanation of symbols]

[0465] 5.10 List of References 1000 patients 1001 Nostril Contour 1002 Nose Bottom Contour 1100 Bedmate 3000 Patient Interface 3100 Seal forming structure 3102 Nostril opening 3104 Bridge part 3106 Plenum chamber connection opening 3108 Lateral support area 3109 Anterior area 3110 Positive lateral area 3112 Nose bottom area 3114 Intermediate area 3115 Corner area 3116 Upper lip area 3117 Nasal tip area 3150 Flexible area 3200 Plenum Chamber 3201 Internal opening 3202 Plenum chamber side end 3204 Plenum Chamber Connector 3206 Notch 3208 Beveled Edge 3209 Slots 3210 Tendon 3220 Top point 3230 Down 3240 Ventilation Insert Opening 3242 Ventilation insert 3260 Plenum chamber part 3300 Positioning and stabilizing structure 3302 Lateral site 3304 Upper part 3306 Hub 3308 Tab 3310 Rear strap 3311 Rear strap end 3312 Sleeve 3314 End 3316 Receiver 3318 Clip Overmold 3320 clips 3322 Clip protrusion 3324 Lip 3400 Plenum chamber vent 3402 Decoupling structure ventilation section 3500 Uncoupling structure 3502 Swivel Connector 3504 Button 3600 Connection Port 3700 Forehead support 4000 RPT Devices 4010 Outer Housing 4012 Upper 4014 Lower 4015 Panel 4016 Chassis 4018 Handle 4020 Pneumatic Block 4110 Air Filter 4112 Inlet Air Filter 4114 Outlet Air Filter 4120 Muffler 4122 Inlet muffler 4124 Exit muffler 4140 Pressure Generator 4142 Blower 4144 Motor 4160 Anti-spillback valve 4170 Air Circuit 4171 Heated Air Circuit 4180 Supplemental Oxygen 4200 Electrical Components 4202 Printed Circuit Board Assembly (PCBA) 4210 Power supply 4220 Input Device 4230 Central Controller 4232 Watch 4240 Therapy Device Controller 4250 protection circuit 4260 Memory 4270 Converter 4272 Pressure Sensor 4274 Flow Sensor 4276 Motor Speed ​​Converter 4280 Data Communication Interface 4282 Remote external communication network 4284 local external communications network 4286 Remote External Device 4288 local foreign device 4290 output device 4292 Display Driver 4294 Display 4300 Algorithm 4330 Treatment Control Module 5000 humidifier 5002 Humidifier inlet 5004 Humidifier outlet 5006 Humidifier Base 5110 Reservoir 5120 Conductive parts 5130 Humidifier Reservoir Dock 5135 Lock lever 5150 Water Level Indicator 5210 Humidifier Converter 5212 Pressure Transducer 5214 Flow Converter 5216 Temperature Converter 5218 Humidity Sensor 5240 heating element 5250 Humidifier Controller 5251 Central Humidifier Controller 5252 Heating Element Controller 5254 Air Circuit Controller

Claims

1. 1. A patient interface, comprising: At least 6 cmH above ambient air pressure 2 a plenum chamber pressurizable to an elevated therapeutic pressure, said plenum chamber including a first plenum chamber inlet port sized and configured to receive an air flow at the therapeutic pressure for breathing by a patient; a seal-forming structure constructed and arranged to seal against an area of ​​a patient's face surrounding an entrance to the patient's airway, said seal-forming structure having two nasal openings separated by a bridge portion whereby a flow of air at said therapeutic pressure is delivered through the nasal openings to the patient's nares, said seal-forming structure constructed and arranged to maintain said therapeutic pressure in a plenum chamber throughout the patient's respiratory cycle, in use; a positioning and stabilising structure configured to hold the seal-forming structure in a therapeutically effective position on the patient's head, said positioning and stabilising structure including a tie, said tie constructed and arranged such that in use at least a portion of said tie rests on a region of the patient's head above an upper ear base point of the patient's head; a vent structure including a plurality of vent holes formed within the plenum chamber and configured to allow a continuous flow of patient exhaled gases from within the plenum chamber to the surroundings, the vent structure being sized and shaped to maintain the therapeutic pressure within the plenum chamber in use; Including, the patient interface is configured to leave the patient's mouth exposed during treatment; the seal-forming structure is shaped and dimensioned such that, in use, no part of the seal-forming structure enters a nares of a patient; the seal-forming structure is shaped and dimensioned so as not to engage the patient's nose above a nasal tip; The seal forming structure includes: an intermediate region having a first thickness, wherein the nostril opening passes through the seal-forming structure in the intermediate region; two positive lateral regions, each of the two positive lateral regions having a second thickness and each of the two positive lateral regions positioned laterally outward of and adjacent to a corresponding lateral side of the intermediate region across a first boundary; two lateral support regions, each of the two lateral support regions having a third thickness, each of the two lateral support regions being positioned laterally outward of and adjacent to a corresponding one of the two positive lateral regions across a second boundary, and each of the two lateral support regions being positioned laterally outward of and adjacent to a corresponding one of the two positive lateral regions across a third boundary; Including, the positive side region being thicker than the intermediate region and thinner than the side support region; A patient interface, wherein the plenum chamber is constructed to be rigid when subjected to an internal pressure of less than about 30 cm H2O above atmospheric pressure.

2. the seal-forming structure further comprises two corner regions, each of the two corner regions configured to engage the patient's face at a corresponding alar nadir region; 2. A patient interface as described in claim 1, wherein the first boundary, the second boundary, and the third boundary on each lateral side of the seal-forming structure converge at a point located in a corresponding one of the two corner regions.

3. A patient interface according to claim 1 or claim 2, wherein the bridge portion is relaxed in an undeformed state.

4. The patient interface of claim 3 , wherein the bridge portion is thicker than the intermediate region.

5. A patient interface according to claim 3 or claim 4, wherein each of the nostril openings is surrounded by the intermediate region and the bridge portion.

6. A patient interface according to any preceding claim, wherein the seal-forming structure is constructed from a flexible material.

7. The patient interface of claim 6 , wherein the flexible material is silicone.

8. 8. A patient interface according to any one of claims 1 to 7, wherein the plenum chamber includes an inner surface and an outer surface, the inner surface being arranged to be at the therapeutic pressure in use and the outer surface being arranged to be at ambient pressure in use.

9. A patient interface according to any preceding claim, wherein the plenum chamber is constructed from a rigid plastic material.

10. A patient interface according to any preceding claim, wherein the plenum chamber is constructed from a transparent material.

11. A patient interface according to any preceding claim, wherein the intermediate region extends to a front side of the seal-forming structure that is not in contact with the patient in use.

12. A patient interface according to any preceding claim, wherein the intermediate region extends to a front side of the seal-forming structure above the seal-forming structure.

13. A patient interface according to any preceding claim, wherein the intermediate region extends below the seal-forming structure to a front side of the seal-forming structure.

14. A patient interface according to any preceding claim, wherein the positive lateral region extends to a front side of the seal-forming structure that is not in contact with the patient in use.

15. A patient interface according to any preceding claim, wherein the positive lateral region extends to a front side of the seal-forming structure on top of the seal-forming structure.

16. A patient interface according to any preceding claim, wherein the positive lateral region extends to a front side of the seal-forming structure below the seal-forming structure.

17. A patient interface according to any preceding claim, wherein the bridge portion is curved as it approaches the plenum chamber to avoid contact with the bridge of the patient's nose in use.

18. A patient interface according to any preceding claim, wherein the intermediate region is disposed between the lateral regions such that the lateral regions are separated from one another.

19. A patient interface according to any preceding claim, wherein the intermediate region and the lateral region are disposed between the lateral support regions such that the lateral support regions are separated from one another.

20. A patient interface according to any preceding claim, wherein the positive lateral region is configured, in use, to avoid at least one of the patient's upper lip, cheeks, nasal tip, and subnasal point.

21. the plenum chamber includes a second plenum chamber inlet port, the first plenum chamber inlet port and the second plenum chamber inlet port being positioned on corresponding lateral sides of the plenum chamber; 21. A patient interface according to any one of claims 1 to 20, wherein the positioning and stabilising structure comprises a pair of conduits, each of the pair of conduits configured to be positioned on a corresponding lateral side of a patient's head in use, each of the pair of conduits having a first end removably connected to a corresponding one of the first and second plenum chamber inlet ports to direct the air flow at the treatment pressure into the plenum chamber.

22. 22. A patient interface according to claim 21, wherein the ties are connected to each of the pair of conduits.

23. the positioning and stabilizing structure comprises a hub, and each of the pair of conduits has a second end connected to the hub; 23. A patient interface as described in claim 21 or 22, wherein a decoupling structure having a further vent is rotatably connected to the hub and configured to be connected to an air delivery circuit to receive the air flow at the therapeutic pressure.

24. the first thickness of the intermediate region is constant throughout the intermediate region; the second thickness of each of the two positive lateral regions is constant throughout each of the two positive lateral regions; A patient interface according to any one of the preceding claims, wherein the third thickness of each of the two lateral support regions is constant throughout each of the two lateral support regions.

25. the intermediate region further includes an upper lip region at least partially bounded by each of the third boundaries and configured to contact an upper lip of the patient in use; A patient interface according to any preceding claim, wherein a shortest distance between each of the third boundaries across the upper lip region is less than or equal to a shortest distance between each of the second boundaries across the upper lip region.

Citation Information

Patent Citations

  • Cradle cushion with lateral stabilizers

    JP2015522369A

  • PATIENT INTERFACE AND METHOD FOR FORMING A PATIENT INTERFACE

    JP2016538049A

  • Patient interface

    US20090044808A1

  • Mask vent

    US20090050156A1

  • Nasal puff with adjustable sealing means

    US4782832A